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Summary
 
The first two to five years of illness are considered a critical period in the development 
of psychotic disorders. It is during this period that adequate treatment may substantially 
impact the course and outcome of illness.  Early intervention has thus become a primary 
goal. Guidelines recommend combined treatments that include both 
psychopharmacological and psychosocial treatments. A wide range of psychosocial 
treatments are offered and established as evidence based. 
In schizophrenia spectrum disorders poor patient engagement can be an obstacle to 
treatment success, and drop-out represents a major challenge. The construct of 
engagement in relation to mental health services is complex and is often studied through 
various components, such as alliance, compliance, and measures of attendance. The 
therapeutic alliance is identified as important in schizophrenia both for engagement and 
outcome, relating to important aspects of treatment such as better compliance with 
medication, lower drop-out rates, fewer rehospitalizations and improved symptom 
levels. This warrants identification of factors that may influence service engagement 
and the quality of the therapeutic alliance. 
Characteristics of the working alliance, and factors associated with quality of the 
working alliance and engagement with services, in the early phase of schizophrenia 
spectrum disorders were studied.
All three papers included in this thesis originate from the ongoing Thematically 
Organized Psychosis (TOP) research study. The main inclusion criterion for all three 
studies was an early phase schizophrenia spectrum psychosis (including schizophrenia, 
schizophreniform disorder, schizoaffective disorder, and delusional disorder. Study I, 
also included psychosis not otherwise specified, and brief psychosis) according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). In 
study I, 148 patients were included with first-episode schizophrenia spectrum psychosis 
(in- and outpatients), recruited from all major psychiatric treatment units in Oslo, 
Norway. The data from studies II and III included 42 patients with early schizophrenia 
spectrum psychosis, included from out- and inpatient services at the Division of 
Psychiatry, St. Olav’s Hospital, Trondheim University Hospital, Norway. Data were 
analyzed on clinical and neurocognitive variables as well as engagement with services 
in study I. Clinical and neurocognitive variables as well as working alliance were 
analyzed in study II. Clinical variables, traits of personality, interpersonal problems and 
working alliance were analyzed in study III. 
Taken together, the results of the studies showed, that patients’ conceptualizing ability, 
together with positive and excitative symptoms explained 18% (adjusted R²) of the 
variance in availability to treatment. Patients’ age, level of excitative symptoms and 
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Submissive/Hostile interpersonal problems accounted for 37% (R²) of the observed 
variance patient total working alliance scores. Patients’ insight and personality trait of 
Agreeableness accounted for 23% (R²) of the observed variance in therapist total
working alliance scores. 
In conclusion, this thesis provide new knowledge about the importance of recognizing 
patients’ individual profiles of symptoms, characteristic basic traits of personality and 
interpersonal problems, with regards to their possible impact on the quality of the 
working alliance in early schizophrenia spectrum disorders, as well as the relation 
between active psychotic symptoms, cognition and patients availability to treatment in 
the early phase of illness. These findings may improve therapist interventions when 
providing psychosocial treatment to patients with early schizophrenia spectrum 
disorders. 
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1.0 Introduction
1.1 Schizophrenia spectrum disorders
Schizophrenia is generally considered the most serious of mental disorders, described 
since antiquity, and found in all cultures [1, 2]. It is characterized by a broad range of 
unusual experiences and behaviors that cause profound disruption in the lives of people 
suffering from the condition, as well as in the lives of the people around them. 
Descriptions and emphasis in diagnostic definitions have been changing since 
Kraepelin’s definition of Dementia Praecox in the late 1800s, and Bleuler’s introduction 
of the term schizophrenia in 1908 [2, 3]. Core features nevertheless consist of pervasive 
patterns of distorted perceptions of reality, through various manifestations such as 
disorganization of thoughts, affective life, behavior and basic sense of self, as well as 
delusions and hallucinations. Central to the understanding of the core disturbance in 
schizophrenia is the disturbance of the basic sense of self, which is more profound than 
in other disorders with psychotic features. On multiple levels of awareness, the 
individual’s natural and self-evident experience and knowledge of being a stable and 
organized self is disrupted. Likewise, the natural experience of effortless perception and 
understanding of the world and occurring events may become strained or lose its 
everyday and common-sense like quality. This affects not only the subjective 
experiences of the individual, but also his or her ability to relate to and interact with 
others [3-5].
Symptoms of schizophrenia have been theoretically organized in different ways by 
different authors, from Bleuler’s “four A’s”: Associative disturbances, affective 
disturbances, ambivalence and autism, to Schneider’s first and second rank symptoms, 
with and without bizarre qualities, Huber and colleagues’ emphasis on the presence of 
subjectively experienced basic symptoms that progress from non-psychotic anomalies to 
the schizophrenic break down of reality, and the contemporary classification of positive, 
negative and disorganized symptoms which can be found in current diagnostic manuals. 
As defined by the Positive and Negative Syndrome Scale (PANSS) positive symptoms 
include delusions, hallucinations, agitation, grandiosity, paranoia and hostility. Negative 
symptoms include withdrawal, apathy, blunted affect, poverty of speech, disturbance of 
volition, overly concrete and stereotyped thinking, while disorganized symptoms 
include various disturbances of thought, behavior, perceptions and disorientation  [1, 3, 
5, 6].  Taken together, definitions vary with regards to their emphasis on the observable 
versus the subjectively experienced, the presence of bizarre qualities, importance of 
affective elements, disorganization of the self and/or behavioral disturbances. These are 
all differences that may arise from differential emphasis on either achieving optimal 
reliability of diagnostics or describing validly the phenomenological qualities of the 
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disorder(s).  Rather than competing accounts of reality, these varying descriptions could 
more adequately be viewed as attempts to give as useful as possible taxonomies for the 
core syndromes of the schizophrenia spectrum. As such, they should always be applied 
within a framework of broad knowledge of psychotic illnesses and their complexity [7].
As originally proposed by Bleuler in 1911 [2, 8], there is however growing consensus 
that schizophrenia is more adequately referred to as not one, but several related illnesses 
constituting a syndrome spectrum, and thus termed the schizophrenia spectrum 
disorders [9].
Contrary to earlier beliefs, there is considerable variation in incidence both between and 
within countries and various populations, with most estimates ranging from eight to 
43/100.000 and median rates around 15/100.000. Schizophrenia affects without regard 
to gender, race, social class or culture, but epidemiological research indicates that 
incidence rates are higher in rural areas, among migrants and that the disorder occurs 
more often in men. The illness most often has its debut in late adolescence or early adult 
years, with a mean debut age around 24 for men and 25 for women. Late onset 
schizophrenia (after the age of 50) although rare in itself, is more common in women. 
Median lifetime risk of schizophrenia is estimated between 0.7 and close to 1%, and 
about half of the patients suffer from a chronic course of illness [5, 10, 11]. Typically, 
the so-called positive and disorganized symptoms tend to appear in an episodic manner, 
while the negative symptoms more often remain in otherwise stable periods in the 
course of illness [12]. Schizophrenia spectrum disorders present with disabling 
psychiatric symptoms. Most patients also have a broad range of difficulties in social and 
occupational functioning and extensive, long term need for health care services [13].
Little is still known about its etiology [14] and much emphasis is thus placed on 
prevention and early detection of the disorder [15].
1.2 Early phase of psychotic illness
Abandoning earlier beliefs, that the syndromes in the Schizophrenia spectrum were 
inevitably progressive poor outcome disorders, a vast body of research and clinical 
services has emerged targeting the early phases of psychotic illness [16]. Early 
prevention of Schizophrenia has been the ultimate goal of these efforts, as well as 
improving outcome of treatment and quality of life for already affected patients [17].
The first two to five years of illness are considered a critical period in the development 
of psychotic disorders. It is during this period that adequate treatment may substantially 
impact the course and outcome of illness. Early psychosis research has established that 
the duration of untreated psychosis (DUP: i.e. the period from the first appearance of 
positive psychotic symptoms to start of adequate treatment) is associated with delayed 
and incomplete remission of symptoms, need for longer durations of treatment and 
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heightened risk of relapse, greater risk of depression and suicide, more drug and 
behavior related problems, more school and work related problems as well as increased 
costs of treatment [12, 18, 19]. Early intervention has thus become a primary goal in 
treatment of psychosis [12, 16, 20]. Despite these efforts, patients with schizophrenia 
still have an increased risk of drop-out before adequate recovery [21, 22]. In addition to 
the objective of reducing DUP, the main target of “post-detection” intervention is thus 
to engage patients in adequate psychopharmacological and psychosocial treatments, 
preventing drop-out and non-compliance, as effectively as possible [16].
1.3 Treatment
Treatment in schizophrenia spectrum disorders was since the 1950s increasingly based 
on antipsychotic medication; with less hope for the benefits of other treatment 
interventions. Belief in psychotherapeutic or other non-pharmacological treatments 
weakened, as results from scientific studies were more clear-cut and positive with 
regards to medication. This trend continued until the emergence of research on 
cognitive-behavioral theories of treatment in psychosis almost forty years later [23].
Today, a wide range of psychosocial treatments are offered and established as evidence 
based. Guidelines recommend combined treatments that include both 
psychopharmacological and psychosocial elements [24]. A recent review, from The 
Schizophrenia Patient Outcomes Research Team (PORT) gives a summary of current 
evidence-based treatment interventions for persons with schizophrenia [25]: For 
psychopharmacological treatment, they include antipsychotic medication other than 
Clozapine and Olanzapine for first episode of acute positive symptoms in 
schizophrenia. For later episodes and relapse prevention, it is recommended that 
antipsychotic medication is chosen on the basis of previous treatment response, 
previous experiences of side effects, history of medication adherence, other relevant 
medication history and risk factors, as well as individual preferences and long term 
planning. For patients with persisting residual symptoms in treatment resistant 
schizophrenia, lasting symptoms of hostility or violent behavior, and for patients with 
persistent suicidality, Clozapine is recommended. For psychosocial treatments, the 
recommendations are Assertive Community Treatment, Supported Employment, Skills 
Training for community functioning, Cognitive Behavioral Therapy, Programs of social 
learning (Token Economy Interventions), Family Based Services, Interventions for 
comorbid Alcohol and Substance Use Disorders, and Interventions for Weight 
management. The PORT statement also summarizes new psychosocial treatments of 
interest, which have not yet achieved sufficient evidence. These are Cognitive 
Remediation Therapy, Peer Support and Peer Delivered Services, Interventions to 
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Increase Adherence to Medication and special Psychosocial Treatment Programs for 
Recent Onset Schizophrenia.  
1.4 Engagement with services
The construct of engagement in relation to mental health services is complex and is 
often studied through various components, such as alliance, compliance, and measures 
of attendance. The patients’ relation to mental health services as a whole, however, may
be quite different from his or her way of relating to its various sub-components. As no 
one definition of service engagement exists, choice of measures is usually determined 
by the main topic of interest [26]. In schizophrenia spectrum disorders poor patient 
engagement can be an obstacle to treatment success, and drop-out represents a major 
challenge to psychosocial treatments [27].  Estimates of drop-out rates are reported from 
about 17% in patients with serious mental illness, 25% in cases of schizophrenia and 
bipolar disorder, to 30% in schizophrenia or psychotic illness cases [21]. In contrast to 
studies of compliance with pharmacological treatments, patient engagement with non-
pharmacological treatments and services has been far less studied. A recent meta-
analysis [27] however indicates a drop-out rate of 13% for psychosocial treatment in 
schizophrenia spectrum disorders. Low engagement with treatment, as assessed by the 
Service Engagement Scale (SES) [28], is associated with several patient related factors, 
ranging from childhood physical abuse, lack of knowledge of consumer rights and the 
specific personality traits of agreeableness and neuroticism [29] to clinical symptoms 
(PANSS positive and excitative symptoms) and neurocognitive measures 
(conceptualization) [30]. Service engagement is also closely associated with the 
therapeutic alliance [29]. 
1.5 The therapeutic alliance
Across patient groups and treatments, the therapeutic alliance is regarded a common 
therapeutic factor, with importance for successful treatment outcomes [31]. Authors use 
different terms to describe this alliance, however the terms most often used are the 
therapeutic-, helping- or working alliance. The latter refers to Bordin’s [32] formulation 
of a therapeutic relationship defined by the level of agreement on the tasks and goals of 
therapy, as well as the development of a personal bond between patient and therapist.
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1.5.1 The therapeutic alliance in schizophrenia
The therapeutic alliance is also identified as important in schizophrenia both for 
engagement and outcome, relating to important aspects of treatment such as better 
compliance with medication, lower drop-out rates, fewer rehospitalizations  and 
improved symptom levels [33-37]. This warrants identification of factors that may 
influence the quality of the therapeutic alliance [33, 38-41].
Most studies on the therapeutic alliance in schizophrenia spectrum samples have 
focused on the predictive value of psychotic symptoms [35, 42, 43], insight [35, 39, 41, 
44] and social abilities [33, 37, 41]. Results have been varied, with the most consistent 
results for insight being positively associated with patient ratings and social abilities 
with therapist ratings of the alliance. While neurocognitive factors have been shown to 
influence the level of service engagement, there are limited reports of their relation to 
working alliance. A small study of twenty-four patients with chronic schizophrenia 
spectrum disorders, found that poorer verbal memory was associated with better patient 
ratings of working alliance, while better therapist ratings were associated with better 
visuo-spatial reasoning [40].
Alliance research in these patient groups have mostly been conducted as part of studies 
on standardized treatment programs (e.g. cognitive-behavioral therapy (CBT) and 
cognitive remediation therapy (CRT)) [33, 35, 37, 39, 44, 45] possibly limiting 
generalizability to other treatment settings.  
There are a very limited number of studies investigating the therapeutic alliance in early 
schizophrenia or other early psychosis samples, i.e. without the possible confounding 
influences of previous therapeutic experiences.
Primarily studies have explored the therapeutic alliance in patient samples with long 
duration of illness and multiple previous hospitalizations, both factors that potentially 
may affect the alliance over time. One early psychosis study [46] found quality of life, 
insight, medication side effects (negatively associated) as well as friendship and  leisure 
activities (positively associated) to account for 22% of the variance in patient rated 
working alliance. Another study, investigating group therapy for early psychosis [45]
reported only a social support subscale termed attachment as predictive of patient rated 
alliance, explaining 18% of the observed variance. One study, using the Psychotherapy 
Status Report [34] has reported that therapists found it more difficult to engage young 
patients in cognitive-behavioral therapy (CBT) or supportive therapy than older 
patients. No other data associated with therapeutic alliance were reported from this 
study [47].
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Interest has over time turned towards more in-depth examination of factors that can 
influence the quality of the therapeutic alliance, including the degree of shared opinion 
between patient and therapist regarding the quality of the alliance [33, 35, 38, 39, 48].
1.5.2 Patient and therapist agreement on the therapeutic alliance
Results from studies investigating patients’ and therapists’ agreement about the quality 
of the therapeutic alliance have been mixed; where some report a significant association 
between their ratings [40, 41, 43, 45] and others do not [33, 39, 49]. Some studies 
however indicate that patients give higher ratings than the professional regarding the 
level of alliance [39, 41, 43, 49, 50] while others report no significant difference 
between patient and therapist scores [44].
1.6 Neurocognition
Impaired cognition is a significant predictor of dysfunction before, during, and after 
treatment of schizophrenia. Two extensive reviews by Green and colleagues [51, 52]
indicate that key areas of cognition impaired in schizophrenia are secondary and 
immediate memory, vigilance, executive functioning, verbal fluency, early visual 
processing, and psychomotor skills. 
1.6.1 Neurocognition and outcome
Most prominently, secondary memory seems to be related to a broad range of outcome 
domains including activities of daily living, social problem solving/instrumental skills, 
and psychosocial skill acquisition. Immediate memory is related to the ability to acquire 
psychosocial skills, while executive functioning and verbal fluency are associated with 
activities of daily living. Vigilance measures in particular appear linked to social 
problem solving and to instrumental skills [51, 52].
Recent research has explored how neurocognition may affect outcome through indirect 
pathways, such as functional capacity and social cognition [53-56]. This link suggests 
that better functional outcomes in patients with schizophrenia spectrum disorders may 
depend on treatment approaches that target several interrelated aspects of functioning, 
from basic cognitive functions to the complex task of mastering daily life. 
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The various aspects of social and daily-life functioning that seem affected by 
neurocognition, also bear similarity to necessary elements of active participation in 
psychosocial treatment. 
1.6.2 Neurocognition and treatment engagement
Actively engaging in treatment requires the practical ability to make and keep 
appointments, skills of social cognition to benefit from therapeutic intervention, 
psychosocial skills to cooperate with a therapist, and social problem-solving skills to 
negotiate therapeutic dilemmas or interruptions. Nevertheless, few studies have 
explored the effect of impaired cognition on service engagement or related concepts. 
One study on middle-aged and older outpatients with a diagnosis of schizophrenia, 
reported that conceptualization (defined as abstraction abilities) and memory (defined as 
a combined measure of secondary and immediate memory plus orientation) were the 
strongest predictors of the ability to manage medication [57]. This study supported the 
notion that cognition is important for adequate treatment adherence. Another study [40]
found an association between neurocognitive measures and therapeutic alliance in a
small sample of patients with schizophrenia. Specifically, impaired verbal memory was 
associated with patient reports of a more positive alliance, while better visuo-spatial 
reasoning was associated with therapist reports of a more positive alliance. Despite 
limitations due to sample size and the narrow perspective on therapeutic alliance, these 
observations also suggest the need for further exploration of the associations between 
patient cognitive functioning and the ability to engage in treatment. 
1.7 Personality 
Across cultures and languages, human personality is generally described as 
characteristic and lasting individual patterns of thought, feelings and behavior [58].
Traits of personality differs from more temporary moods or states that may characterize 
an individual, by being typically more stable and enduring [59]. After almost 90 years 
of research and debate on the language and structure of personality, researchers seem 
mostly to agree on a five-factor model as a unifying theory that serves to describe the 
most basic factors of personality; Extraversion/Introversion, Friendliness/Hostility, 
Conscientiousness, Neuroticism/Emotional stability and Intellect/Openness [60].
Generally the Extraversion/Introversion factor describes how much and to what degree 
a person prefers to interact with others, as well as his or her level of activity and 
exuberance. The Friendliness/Hostility (Agreeableness) factor is mainly interpersonal, 
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and describes preferred type of interpersonal interaction on a dimension ranging from 
warm/empathic to hostile/ruthless. Conscientiousness refers to ability to be organized, 
well controlled, persistent, and goal-directed. Neuroticism/Emotional stability reflect to 
what extent a person tends to experience psychological distress or negative 
emotionality, as well as degree of emotional adjustment. The Intellect/Openness factor 
describes a person’s tendency to be active and seeking in search of new experiences, as 
well as his or her level of curiosity, imagination and unconventionality [59].
1.7.1 Personality in schizophrenia
It has been fairly well documented that basic traits of personality as defined by the five 
factor model of Costa and McCrae [58, 61], are applicable and stable also in 
schizophrenia [62-66]. In general, there are consistent reports of schizophrenia samples 
scoring higher on neuroticism and lower on conscientiousness relative to both other 
patient groups and normal control samples, and some reports of low scores on 
extraversion, agreeableness and openness as well [66, 67]. It has been reported that 
higher levels of neuroticism are associated with higher levels of positive psychotic 
symptoms, while reports of associations between extraversion, agreeableness and 
psychotic symptoms have been mixed [62, 68]. One study found that frequency of 
social interaction was predicted by agreeableness, negative symptoms, verbal memory 
and (at trend level) neuroticism. Capacity for intimacy was predicted by negative 
symptoms, agreeableness, openness, conscientiousness and (at trend level) positive 
symptoms [69]. Another study, on early psychosis, reported that higher levels of 
neuroticism and lower levels of agreeableness, together with childhood physical abuse, 
lack of knowledge concerning consumer rights and quality of therapeutic alliance, could 
account for 31% of the variability in engagement with treatment services [29].
1.7.2 Personality and the therapeutic alliance
Across theoretical models, methods and groups of patients, the interpersonal aspect 
remains a common element to the different forms of psychotherapy and psychosocial 
treatments [70]. Relational measures can be direct measures of relational behavior or 
indirect measures of individual characteristics that influence how a person feels about 
and relates to others. Core traits of personality and patterns of interpersonal problems 
are examples of individual characteristics with considerable relational impact.  
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In non-psychotic axis I psychiatric disorders [71, 72] and axis II borderline personality 
disorder [73], aspects of general personality traits have been associated with formation 
of the therapeutic alliance, although some have reported the alliance unrelated to traits 
of personality [74]. It has been documented in non-psychotic samples that interpersonal 
problems predict the quality of the therapeutic alliance [75-78].
2.0 Aims
The main aim of the thesis was to describe characteristics of the working alliance, and 
to identify predictors of the quality of the working alliance and engagement with 
services, in the early phase of schizophrenia spectrum disorders.
The aim of paper I, was to examine the influence of neurocognitive deficits on 
engagement with services as measured by the SES. Relationships between clinical 
symptoms and service engagement were also explored.
The aim of paper II, was to analyze to what extent demographic, clinical and cognitive 
characteristics influence patients’ and therapists’ reports of working alliance, as well as 
to what degree there is an association between their ratings of the therapeutic alliance.
The aim of paper III, was to explore if traits of personality and dimensions of 
interpersonal problems in patients in the early treated phase of schizophrenia spectrum 
disorders are associated with patients’ and therapist’ experience of the working alliance.
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3.0 Methods
3.1 Design of the studies
The studies included in this thesis, had a cross-sectional design and originate from the 
ongoing Thematically Organized Psychosis (TOP) research study [79, 80].
3.1.1 Study I
Study I included 148 patients with first-episode schizophrenia spectrum psychosis (in-
and outpatients), recruited from all major psychiatric treatment units in Oslo, Norway. 
Being defined as first-episode patient required not previously on any occasion having 
been treated with antipsychotic medication in adequate dosage for more than 12 weeks 
(or until remission). Present psychosis was defined as having a rating of 4 or more on 
PANSS items P1, P2, P3, P5, P6, or G9 for more than one week. Patients were recruited 
up to 52 weeks following the start of adequate medication or hospitalization for 
psychosis.
3.1.2 Study II and III
In studies II and III 49 subjects were included consecutively in the period from 
December 2006 to November 2011, from out- and inpatient services at the Division of 
Psychiatry, St. Olav’s Hospital, Trondheim University Hospital, Norway. Additional 
exclusion criterion for study II and III was comorbid cluster A or B personality disorder 
according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV), determined by clinical consensus based on evaluation of the criteria. 
Subjects were recruited up to two years following the start of their first schizophrenia 
spectrum psychosis episode and up to one year after establishing contact with their 
current treating psychologist or psychiatrist. Seven of those who consented were 
subsequently found ineligible and excluded from the analyses for the following reasons; 
longer duration of illness than allowed by inclusion criteria (two), inadequate language 
abilities for completing the neurocognitive test battery (two), primary diagnosis of 
bipolar disorder (one), withdrawal of consent (one), drop out without actively 
withdrawing consent (one). Data from 42 subjects were thus entered in the statistical 
analyses.
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Table 1. Descriptive statistics for demographic data and psychotic symptoms
Study I Study II/III
Age (Mean ± SD) 35.0 (± 9.8) 27.5 (± 5.6)
Education (Mean ± SD) 12.6 (± 2.5) 11.8 (± 1.9)
Gender N (%)
Male 84 (56.8) 28(66.7)
Female 64 (43.2) 14(33.3)
Diagnosis N (%) 148 (100) 42 (100)
Schizophrenia 94 (63.5) 36 (85.7)
Schizoaffective disorder 27 (18.2) 3 (7.1)
Delusional disorder 4 (2.7) 3 (7.1)
Schizophreniform disorder 6 (4.1) 0 (0)
Brief psychotic disorder 1(0.7) 0 (0)
Psychotic disorder not otherwise specified 16 (10.8) 0 (0)
Medication N (%)
Antipsychotic 127 (85.8) 33 (78.6)
Mood stabilizers 3 (2.2) 4 (9.5)
Antidepressive only 3 (2.2) 1 (2.4)
No medication 15 (10.1) 8 (19.0)
PANSS (Mean ± SD)
Total score 58.2 ± 16.7 66.9 ± 15.6
POSITIVE (P1, P3, P5, P6, G9, G12) 14.1 ± 5.9 17.0 ± 5.6
DISORGANIZED (P2, N5, N7, G5, G10, G11, G15) 11.0 ± 3.8 13.1 ± 4.3
NEGATIVE (N1, N2, N3, N4, N6, G7, G16) 14.4 ± 6.6 15.4 ± 6.1
DEPRESSIVE/ANXIOUS (G1, G2, G3, G4, G6) 11.8 ± 4.4 13.4 ± 4.5
EXCITATIVE (P4, P7, G8, G14) 5.3 ± 1.8 5.9 ± 2.2
PANSS = Positive and Negative Syndrome Scale; SD = Standard Deviation.
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3.2 Samples
Inclusion criteria for all three studies were: 1) a schizophrenia spectrum psychosis 
(including schizophrenia, schizophreniform disorder, schizoaffective disorder, and 
delusional disorder; study I also included psychosis not otherwise specified, and brief 
psychosis) according to the DSM-IV; 2) age 18 - 65 years; 3) capacity to supply written 
informed consent; 4) adequate language abilities to complete the neurocognitive test 
battery. Exclusion criteria were a history of moderate/severe head injury, neurological 
disorders, or mental retardation (IQ less than 70). Descriptive data are shown in table 1. 
3.3 Measures
All three studies: Diagnoses were set by use of the Structured Clinical Interview for 
Diagnostic and Structural Manual of Mental Disorders (SCID), fourth version [28]. The 
Positive and Negative Symptom Scale (PANSS) [29] was applied for symptom 
assessment, after interview with the Structural Clinical Interview for the Positive and 
Negative Symptom Scale (SCI-PANSS) [30]. Scale components were scored based on a 
five factor solution derived from a first episode sample [31]; The PANSS Positive 
factor, PANSS Disorganized factor, PANSS Negative factor, PANSS 
Depressive/anxious factor, and PANSS Excitative factor.
Neurocognitive measurements (Study I and II)
Tests were selected based on their relevance to schizophrenia spectrum disorders, 
covering areas of memory, attention, and executive functions, as well as estimates of 
current general intellectual ability. 
3.3.1 Study I
Service engagement
Service engagement was measured with the SES, a clinician-rated scale of 14 items 
concerning the patients’ cooperation and engagement with treatment. The items consist 
of the sums of the clinician’s ratings of various statements, each rated on a scale from 0
("not at all or rarely") to 3 ("most of the time"). The total score is computed by 
summing the four sub-scale scores (0-42); this total score can be sub-divided into four 
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scales assessing “availability,” “collaboration,” “help-seeking,” and “treatment 
adherence.” High total scores reflect low engagement as perceived by the clinician, 
while low total scores reflect high engagement. Due to missing data on a few single 
items, the sub-scale scores were computed with missing scores replaced by the group 
mean of the sub-scale. We also computed an alternative total score by adding the sub-
scales without the missing data (sum of adjusted sub-scales). All references to the SES 
total score are to the sum of adjusted sub-scales. For the purpose of this study, the SES
was adapted to the Norwegian language using back translation; the instrument was first 
translated into Norwegian, then translated back into English and compared to the 
original by two independent researchers with very good knowledge of both languages.
Neurocognitive measurements
Current general intellectual ability was estimated with the Wechsler Abbreviated Scale 
of Intelligence (WASI; Wechsler, 2007), and ability to conceptualize with the 
Similarities sub-test from the WASI. Verbal learning and memory were measured by 
the California Verbal Learning Test (CVLT-II) (Delis et al., 2004) (verbal learning and 
verbal recall) and the Logical Memory test from the Wechsler Memory Scale (WMS-
III) (Wechsler et al., 2007). Executive functions were measured by sub-tests from the 
Delis-Kaplan Executive Function System (D-KEFS); the interference (executive 
control) and the interference-switching (executive flexibility) sub-tests from the Color-
Word Interference Test, and the letter fluency, semantic fluency, and semantic set shift 
sub-tests from the Verbal Fluency Test.
3.3.2 Study II and III
Clinical assessment
In addition to the above mentioned clinical assessments, insight was assessed with the 
PANSS item G12 (“Failure to recognize past or present psychiatric illness or 
symptoms, denial of need for psychiatric hospitalization or treatment, decisions 
characterized by poor anticipation of consequences, and unrealistic short-term and 
long-range planning.”).
Working Alliance
Working Alliance was assessed with the Working Alliance Inventory - Short Version 
(WAI-S) [36], a 12-item short version of the Working Alliance Inventory (WAI) [37]
based on Bordins’ [38] formulation. The WAI-S is a self-report measure with 
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corresponding therapist and patient versions, comprised of twelve statements rated by 
indicating to what degree the statement is considered true on a seven point scale (1= 
never, 2= rarely, 3= now and then, 4= sometimes, 5= often, 6= very often, 7= always). 
Statements number 4 and 10 are formulated as negations and scores therefore reversed. 
Chronbach’s Alpha estimating internal consistency in the range from .69 to .89, 
confirmed good reliability for WAI-S therapist and patient total and sub scores for 
Tasks, Goals and Bond.
3.3.3 Study II
Neurocognitive measures
Current general intellectual ability was estimated by use of four subtests from the 
Wechsler Adult Intelligence Scale (WAIS-III): Similarities, Vocabulary, Block design 
and Matrixes [81]. Verbal memory was measured by the California Verbal Learning 
Test II (CVLT-II) [82]. Executive functions were measured by the Wisconsin Card 
Sorting Test Computer Version 2-Research Edition (WCST: CV2) [83]. Attention was 
measured by Conners Continuous Performance Test II (CPT-II) [84]. 
3.3.4 Study III
Traits of personality
To assess core traits of personality, the NEO Five Factor Inventory (NEO-FFI) [85] was 
used. It assesses the five basic traits of personality; Neuroticism, Extraversion, 
Openness, Agreeableness and Conscientiousness. 
NEO-FFI is a 60 item self-report short version of the NEO Personality Inventory –
Revised (NEO PI-R) [85]. The respondent is asked to indicate on a five point scale the 
degree of his or her agreement with each statement (‘strongly disagree’, ‘disagree’, 
‘neutral’, ‘agree’, ‘strongly agree’). 
Interpersonal problems
To measure interpersonal problems the Inventory of Interpersonal Problems 64 item 
Circumplex version (IIP-64C) [86] was used. The IIP-64C is a self-report measure 
listing a set of 64 different behaviors which the respondent rates on a five point scale as 
difficult or done too much (‘not at all’, ‘a little’, ‘moderately’, ‘quite a lot’, ‘a lot’). 
Eight dimensions of interpersonal problems are computed; Domineering (PA), 
Vindictive (BC), Cold (DE), Socially inhibited (FG), Nonassertive (HI), Exploitable 
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(JK), Overly nurturant (LM) and Intrusive (NO). The eight dimensions constitutes a 
circumplex that forms four quadrants of interpersonal problems; Submissive/Hostile, 
Submissive/Friendly, Dominant/Hostile and Dominant/Friendly [70, 87, 88] (see figure 
1.). 
Figure 1. Theoretical illustration of a two-dimensional circumplex representation of 
interpersonal problems, adapted from Alden, Wiggins and Pincus (1990) and Gurtman 
(1996; 2004). 
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3.4 Procedure
3.4.1 Study I
Patients were assessed by clinical psychologists and psychiatrists trained specifically in 
the use of the measures included in the study protocol. The TOP study’s program show 
good diagnostic reliability both towards gold standard training videos and for blinded 
expert scorings of randomly selected case vignettes from the actual sample. The inter-
rater reliability of PANSS subscales for the training program were in the range of 0.73 –
0.82 (Intra Class Coefficient) (see [89] and [79] for details).
Neurocognitive functioning was assessed by clinical psychologists trained in the use of 
the neuropsychological standardized test battery [90]. The tests were administered in a 
fixed order allowing two breaks at given times, and took three hours to complete.
3.4.2 Study II and III
All diagnoses and assessments were completed by clinical psychologists and 
psychiatrists trained specifically in administration and scoring of the applied measures. 
Scorings were then reevaluated and discussed with the first author, who had completed 
the comprehensive training program used by the TOP study (based on the program used 
at the Semel Institute for Neuroscience and Human Behavior at the University of 
California, Los Angeles, UCLA). Consensus scorings where then applied.
Assessments of diagnoses and symptoms were blind to working alliance scores, as 
patients and therapists separately filled in Working Alliance self-report forms and 
placed them in closed envelopes the same week or as soon as possible after symptom 
assessments. Therapists were the patients’ primary treating psychiatrist or psychologist 
at the hospital. 
3.5 Statistical analyses
All statistical analyses were conducted by using Statistical Package for the Social 
Sciences (SPSS), version 16.0 and 19.0 
In paper I, all tests were two-sided with a pre-set level of significance of 0.05. We used 
independent sample t-tests to compare group means and Pearson’s correlations to 
analyze the correlations among SES total score, relevant cognitive measures, and 
relevant clinical and demographic measures (age, education, number of years on 
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antipsychotic medication, psychotic and affective symptoms). To estimate whether 
variables with significant SES associations were also able to differentiate between high 
and low SES scorers, t-tests were used with a cut-off point of 10 [29]. We performed a 
stepwise multiple linear regression analysis that included relevant predictors with 
statistically significant associations with SES (including only variables with p < 0.1) 
identified in the preparatory analyses (Block 1 symptom measures (positive, excitative, 
disorganized, negative, and depressive/anxious), Block 2 neurocognitive measures 
(conceptualization, letter fluency, and semantic set shift)). Finally, we performed four 
supplementary multiple linear regression analyses with an identical set of predictors as 
in the primary analysis, but with one of the four sub-scales of the SES (availability, 
collaboration, help-seeking, and treatment adherence) as the dependent variable.
Papers II and III, bivariate analyses including WAI-S scores were performed by use of 
nonparametric tests (Spearman’s correlations and Mann-Whitney U test for two 
independent samples) because alliance scores were not normally distributed. Other 
bivariate analyses were performed by use of parametric tests (Pearson’s correlations and 
T-tests). Tests were two-tailed and had a pre-set level of significance of 0.05. 
Hierarchical linear regression analyses with patients’ and therapists’ total WAI-S scores 
were performed to assess the individual contribution from variables with a significant 
bivariate association to the WAI S total and sub scores. Model fit was evaluated through 
examination of residual plots. 
IIP-64C scores were ipsated by subtracting individual IIP-64C total mean score from 
individual sub scale scores. IIP-64C quadrant scores were computed by summing the 
relevant two of the original eight-scale scores in separate procedures for raw and ipsated 
scores.
Due to administrative error one PANSS item G12 (measuring insight), one patient and 
two therapists working alliance assessment forms as well as five IIP-64 and NEO-FFI 
forms were missing. For SES subscales one availability score, four collaboration scores, 
10 help-seeking scores and 11 treatment adherence scores were missing. Also, due to 
individual difficulties in completing all tests, CVLT-II and WCST was not administered 
for one patient and CPT-II for two patients. All missing scores were replaced by mean 
scores for the total sample in our analyses.
3.6 Ethical considerations 
The Regional Committee for Medical Research Ethics and the Norwegian Data 
Inspectorate approved the study. All the participants gave written, informed consent to 
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participate in the study. The study was conducted according to the Declaration of 
Helsinki.
The study protocol was designed to be applicable in a sample of patients with 
schizophrenia spectrum disorders. Even so, it was comprehensive, and some patients 
may have found it hard to complete all interviews, tests and forms. Within 
methodological limits, adjustments were made in such cases accordingly to make 
participation acceptable to each individual. Thus, from some cases there are missing 
data due to difficulties in participating in all aspects of the study.  When conducting 
studies that investigate therapeutic alliance and service engagement in patients with 
severe mental disorders, one could question if participation may have put undue 
pressure on patients or may cause some to feel obliged to participate in order to receive 
optimal treatment. The studies presented in this thesis sought to reduce risk of such 
negative effects, by clearly stating that participation is voluntary, that consent can be 
withdrawn at any time, and that the patient is free to choose not to give certain 
information. This was stated both in the written consent information and verbally before 
inclusion and during assessments. 
4.0 Main results
4.1 Cognition and Service Engagement (paper I)
Of the neurocognitive measures, conceptualization, verbal fluency, and semantic set 
shift were all significantly correlated with SES total score. Clinical symptoms (PANSS 
positive and negative, depressive/ anxious, disorganized and excitative components)
were similarly correlated with SES score, with correlation coefficients in the same 
range. In addition, conceptualization, semantic set shift (but not letter fluency), and all 
PANSS components reliably differentiated between high (> 10) and low (<=10) scorers 
on the SES total. 
All neurocognitive and clinical variables with a significant bivariate correlation with the 
SES total score were entered in a stepwise multiple linear regression model, with SES 
total score as the dependent variable. In the final model the PANSS positive component 
made a significant contribution, while PANSS excitative and negative components had 
a trend-level contribution. Conceptualizing ability retained a significant contribution 
even when entered at the last step. The model was able to account for 15% of the 
variance in the SES total score (adjusted R²).
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Supplementary regression analyses with SES sub-scores as the dependent variable 
indicated that the impact of WASI conceptualizing ability on the SES total score could 
be accounted for by its impact on the SES sub-scale availability. Together with the 
positive and excitative symptoms measured by the PANSS, WASI conceptualizing 
ability accounted for 18% of the variance in SES availability sub-scale score (adjusted 
R²), but did not have a statistically significant influence on any other sub-scales. None 
of the other cognitive predictors displayed explanatory capacity in predicting any of the 
SES sub-scales. Ten percent of the variance in the SES cooperation sub-scale was 
explained by PANSS positive and excitative symptoms. In the SES Help-seeking sub-
scale, 5% of the variance was explained by PANSS negative symptoms, and in the SES 
Adherence sub-scale, 7% of the variance was explained by PANSS positive symptoms.
4.2 Therapeutic alliance in early schizophrenia (paper II)
 
There were no gender differences, or differences between inpatients and outpatients in 
neither patients’ nor therapists’ WAI-S total or sub scores. Patients with longer 
education reported higher levels of WAI-S total and treatment tasks- and goals score.  
Older patients reported higher levels of the treatment tasks score. There were no 
associations between patient demographic characteristics and therapists scores.
Higher scores (i.e. higher symptom loads) for the PANSS Positive factor, and Excitative 
factor was associated with  lower patients’ WAI-S total scores,  in addition to lover 
levels of several sub scores. High scores for the PANSS Negative factor and Excitative 
factor was also associated with lower levels of therapists’ WAI-S total scores, in 
addition to several sub scores. The level of PANSS insight (G12) was not associated 
with patients’ scores but negatively associated with WAI-S therapist total scores in 
addition to several sub scores. There were no association between any of the 
neurocognitive scores and patients’ or therapists’ WAI-S ratings.   
Multivariate linear regression analyses indicated that the best model explaining the level 
of patients’ WAI-S total score was the patient’s age and level of excitative symptoms, 
which explained 23% of the observed variance (R²). For therapist WAI-S total scores, 
the regression analysis indicated that only insight (PANSS item G12) had a statistical 
significant influence and could explain 17% of the observed variance (R²).
There were no differences (numerical or statistical) in the mean level of patient and 
therapist WAI-S total scores (ES 0.09), but with marginally larger variation in patient 
ratings. Patients and therapist’s WAI-S total scores were statistically significantly 
associated and also had moderate degrees of association on the sub score level. An 
exploratory regression analysis with  patients’ WAI-S total score as dependent including 
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therapist’ WAI-S total score as an  independent variable at the last step of the analysis, 
indicated that neither age, PANSS Excitative factor nor PANSS Insight (G12) mediated 
or moderated their level of association. 
4.3 Personality traits, interpersonal problems and therapeutic alliance (paper III)
Patients’ scores for this sample differed significantly from the normative sample mean 
for all NEO-FFI personality traits, with the exception of Agreeableness. Patients scored 
significantly higher on NEO-FFI Neuroticism, and lower on Extraversion, Openness
and Conscientiousness. 
IIP-64C scores were significantly higher (>1 standard deviation) for all dimensions 
except Domineering (PA; > 0.9 standard deviation) compared to a Norwegian normal 
reference sample [91], but at the same level as a Norwegian non-psychotic outpatient 
sample [92]. Scores were highest for the IIP-64C Submissive/Friendly quadrant 
followed by the Submissive/Hostile quadrant and the Dominant/Friendly quadrant, with 
the lowest scores for the Dominant/Hostile quadrant (table 1). Scores in the 
Dominant/Hostile quadrant were significantly lower than the three other quadrants 
(versus Dominant/Friendly t = 2.76, p < 0.010; versus Submissive/Hostile t = 4.33, p 
0.001; and versus Submissive/Friendly t = 5.48, p < 0.001) and in the 
Submissive/Friendly quadrant significantly higher than the three other quadrants (versus 
Submissive/Hostile t = -2.05, p < 0.05; versus Dominant/Friendly t = -3.84, p < 0.001; 
and versus Dominant/Hostile t = -7.24, p < 0.001). There were no differences in NEO-
FFI or IIP-64C scores between men and women or between outpatients and inpatients. 
Higher patient WAI-S total scores were statistically significantly associated with lower 
levels of NEO-FFI Neuroticism and higher levels of Agreeableness, as well as lower 
levels of interpersonal problems in the IIP-64C Submissive/Hostile quadrant in bivariate 
analyses. There was a trend level association (p= .054) between NEO-FFI 
Agreeableness scores and therapist WAI-S total scores but no associations between any 
IIP-64C interpersonal problem scores and WAI-S therapist scores. 
Several NEO-FFI and IIP-64C scores were highly statistically significantly correlated 
and could thus not be fitted in the multiple linear regression analyses at the same time.
The hierarchical linear regression analyses indicated that a model including patients’ 
age, level of PANSS excitative symptoms and IIP-64C Submissive/Hostile had the best 
explanation of WAI-S patient total scores. The model accounted for 37% of the 
observed variance (R²). Hierarchical linear regression analysis with therapist WAI-S
total scores as the dependent variable indicated that PANSS insight (item G12) and 
NEO-FFI Agreeableness accounted for 23% of the observed variance (R²). 
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5.0 General discussion
5.1 Influence of neurocognitive deficits and clinical symptoms on service 
engagement
In paper I, conceptualization (as measured by the WASI Similarities) had a statistically 
significant association with service engagement (as measured by the total score of the 
SES) even after correction for differences in clinical symptoms. In addition, the level of 
active psychotic symptoms as measured by the PANSS positive and excitative 
components contributed significantly. The variance in these three variables taken 
together explained 15% of the variance in service engagement scores. 
Supplementary analyses in paper I indicated that this effect was based on the impact of 
conceptualization on the SES sub score availability, and not related to the other SES 
domains (i.e. cooperation, help seeking or adherence). The SES availability score is 
based on scorings of three statements describing difficulties in arranging appointments 
with the patient. It may well be that the most significant expression of difficulties with 
service engagement would be not showing up for appointments, or actively avoiding 
them. Thus, patients with high (i.e. compromised or poor) SES availability scores could 
be the ones with the lowest overall level of service engagement. Their treating 
professional would then also have less information to score the rest of the sub domains, 
resulting in these being less valid descriptions of service engagement.  The question 
why conceptualization is the primary associated neurocognitive variable remains. We 
here reason that in this context the ability to conceptualize can be understood as closely 
related to the adaptive aspect of general intelligence; i.e. it is a measure of the ability to 
generate higher order concepts, abstracting from experience and learning and building 
new understanding on it. If so, it would be associated with general adaptive skills such 
as understanding which actions are necessary for achieving adequate (professional) 
help, being flexible in negotiating the handling of one’s needs, being present and 
perceptive in one’s life, and generally able to make choices that supports survival. The 
finding of a relationship between conceptualization and service engagement in early 
phase patients is in line with previous findings  that the ability to conceptualize was 
related to the ability to cooperate with treatment in older patients with schizophrenia 
[57].
Results demonstrated that PANSS positive, excitative, disorganized, negative and 
depression/anxiety factors had a significant association with the SES total score in 
bivariate analyses, while only the positive and excitative factors retained their influence 
in the multivariate analyses. This underlines the importance clinical symptoms have in 
creating problems with service engagement. The stronger influence of positive and 
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excitative symptoms indicates that active avoidance of treatment may be more 
important than passive withdrawal, at least in this first episode sample. 
5.2 Influence of demographic, clinical and cognitive characteristics on the working 
alliance
In paper II, results confirmed that patient’s age and level of excitative symptoms were 
the primary predictors of the patients’ ratings of working alliance, while level of insight 
was the strongest predictor of therapists’ ratings. There was no indication of any 
associations between neurocognitive factors and working alliance. This has been 
suggested, but not consistently found in previous studies from more chronic groups [33, 
35, 39-41, 44].
The association between excitative symptoms and patients’ experience of global 
working alliance with therapists seems reasonable from a clinical perspective, as 
excitement, hostility, uncooperativeness and poor impulse control are behaviors 
contingent with negative relational experiences. Such an association has also been 
described in older groups of patients with schizophrenia spectrum disorders [44],
although not consistently [33]. The multivariate regression analyses indicated that the 
bivariate association between total years of education and patient total alliance scores 
was mediated through age differences. This is in line with findings from older and more 
chronic patients, where there is no relationships between education and alliance [35]. 
The association between lower age and poorer patient ratings of working alliance is in 
line with the general observation that early onset schizophrenia is associated with poorer 
prognosis of course of illness and outcome [93, 94].
Insight (i.e. the quality of the patients’ awareness and understanding of their psychiatric 
condition) was the only factor influencing the therapist scores.  Thus, therapists should 
be aware of how this may blur their perception of the quality of the therapeutic relation 
as the patient sees it,  and also of the effect that the lack of insight has on his/her 
personal experience of the cooperation and bond with the patient in early phases of 
treatment. Both aspects could possibly exert a secondary effect on therapist behaviors.
Although often referred to as a clinical symptom, insight is a multifaceted phenomenon 
that have been found related to both symptom severity, DUP, premorbid adjustment, 
cognitive impairment and brain volumes [95].
33 
 
5.3 Association between patients’ and therapists’ ratings of the working alliance
In paper II, WAI-S total score levels for patients and therapists were fairly high and 
comparable to those reported in other studies of schizophrenia spectrum samples using 
the same scale [35, 41, 44]. We found a moderate degree of shared opinion between 
patient and therapist ratings of the quality of the working alliance, with a higher 
concordance in alliance total scores between patients and therapists than in previous 
studies [33, 35, 39, 43, 44]. Multivariate linear regression analyses indicated that the 
association between patient and therapist working alliance total scores were not 
moderated by other predictors of the total scores. The higher degree of shared opinion 
on the working alliance found in this study compared to previous studies, possibly 
reflect a better quality of the therapeutic alliance with patients in early phases of 
schizophrenia spectrum disorders compared to patients with longer duration or more 
chronic courses of illness. If so, this adds weight to the importance of the early 
psychosocial treatment for patients with these disorders.
On the sub scale level, the differential characteristics of patient and therapist 
perceptions of the alliance were reflected in that both goal scores and bond scores were 
unrelated, while tasks scores were moderately associated. The strongest subscale 
associations were between therapist bond scores and patient tasks and goals scores, 
possibly indicating that patient experience of agreement on treatment tasks and goals 
and therapist experience of a stronger relational bond are aspects that are mutually 
dependent on each other. 
5.4 Influence of personality and dimensions of interpersonal problems on the 
working alliance. 
 
In paper III, both core traits of personality and dimensions of interpersonal problems 
were clearly associated with patients’ experience of their working alliance with their 
therapist in bivariate analyses.  In multivariate analyses, the Submissive/Hostile
quadrant of interpersonal problems, together with patient age and level of excitative 
symptoms, accounted for more than one third of the observed variance in patient rated 
working alliance.  
High scores on the IIP-64C Submissive/Hostile quadrant reflects patients experiencing 
problems in feeling and expressing emotional and relational closeness, love and 
affection towards others, difficulties in establishing social relations and making long 
term commitments and in being sociable with others [86, 87]. To our knowledge, the 
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importance of patients’ experience of interpersonal problems for the quality of the 
working alliance has not been previously shown in schizophrenia spectrum disorders. 
These results are consistent with findings from studies indicating that aspects of 
personality are associated with capacity for intimacy and engagement with treatment 
services in schizophrenia [29, 69], and suggest that personality factors may mediate 
these relationships. They are also in agreement with results from non-psychotic patient 
groups, indicating that submissive/hostile interpersonal problems are associated with 
patient reports of getting less out of their psychotherapy sessions compared to other 
patients [88]. In non-psychotic samples, poorer therapeutic alliance has also been found 
to be associated with interpersonal problems in the dominant/hostile domain [78, 96].
This suggests that it could be primarily the hostile elements of interpersonal problems 
that are associated with a poorer therapeutic alliance. 
Scores in the Submissive/Friendly quadrant were significantly higher than for other 
interpersonal problems in this sample. These patients thus mainly experience 
interpersonal problems in being assertive towards others, clearly stating needs, feelings 
and communicating anger because of fear of how others might respond [86]. The 
analyses however indicated that these interpersonal difficulties did not interfere with 
individual therapeutic relationships. From studies of non-psychotic samples it has been 
suggested that friendly/submissive qualities can in fact be  favorable to the process of 
therapy, such as greater openness to self-exploration and change, as well as more 
positive patient ratings of the working alliance [78, 96, 97].
Higher levels of NEO-FFI Agreeableness were associated with therapists’ experience of 
the working alliance in study III. The results thus indicate that patients describing 
themselves as being more empathic, helpful and trusting of others [59], in combination 
with higher levels of insight was important for the therapists experience. Therapist 
working alliance scores showed no association with patient experience of interpersonal 
problems. As NEO-FFI Agreeableness was clearly negatively associated with patient 
reports of interpersonal problems in both hostile quadrants of the IIP-64C, there is 
reason to advice therapists to pay special attention to patients with core traits of 
personality characterized by low agreeableness. This is also in line with results from 
non-psychotic samples [72, 98].
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6.0 Methodological issues
6.1 Limitations of the studies
There are some limitations to consider when interpreting our findings. Generalizability 
of these results may be limited as the study sample size was moderate. Also, subjects 
were assessed in a naturalistic treatment setting and not as part of a standardized
treatment program. This lessened the possibility to standardize timing of assessments in 
detail, and theoretically increased the number of possible confounding variables. The 
cross-sectional explorative design prevents conclusions about causality.  Due to
instances of missing data, some analyses were done with missing scores being replaced 
by the group mean. The inclusion of subjects in these studies was based on informed 
consent. The possibility of implicit selection of patients is relevant to engagement and 
alliance research, as we do not know if non-consenting patients exhibit substantially 
different characteristics on the variables of interest.
6.2 Strengths of the studies
The naturalistic and cross-sectional design may also be viewed as strength of the 
studies, as it provides the thesis with a real-life basis of data, which can be thought to 
reflect the everyday clinical reality for these patients and their therapists.  The data in 
paper I is also based on multi-site inclusion of patients, which strengthens the 
representativeness of the results from this sample. All applied measures are well-known 
and validated instruments with good psychometric properties. Also, both samples in this 
thesis are well characterized and missing data were few. 
7.0 Conclusions
The results presented in this thesis indicate that patients’ engagement with services may 
be influenced by variations in patients conceptualizing abilities as well as positive and 
excitative symptoms. This appears to be partly mediated through an effect on 
availability to treatment, i.e. by influencing to what extent the patient is cooperating by 
making and showing up for appointments. These results support the idea that parts of 
the observed relationships between cognitive deficits and outcome might be mediated 
by aspects of engagement in treatment services. 
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The thesis also describes how patients and therapists qualitative experience of the 
working alliance is associated with specific, but different patient characteristics. 
Compared to other studies, the results indicate that there may be phase specific 
characteristics associated with the quality of the alliance in early phase schizophrenia 
spectrum disorders. Interpersonal problems of Submissive/Hostile character, lower 
patient age and more excitative symptoms predict lower patient ratings of the working 
alliance. Therapists on the other hand, perceive better working alliances with patients 
characterized by higher levels of Agreeableness and insight. Patients in the early phase 
also share opinion with their therapists on the quality of the working alliance to a higher 
degree than patients in later phases of illness. 
8.0 Implications for clinical practice
 
The results from this thesis provide new knowledge about the importance of 
recognizing patients’ individual profiles of symptoms, characteristic basic traits of 
personality and interpersonal problems, with regards to their possible impact on the 
quality of the working alliance in early schizophrenia spectrum disorders. Interestingly, 
these patients exhibit symptom characteristics that are relevant to the working alliance, 
but specific to severe psychotic disorders. However, they are also characterized by 
interpersonal problems and traits of personality with relevance to the alliance that are 
quite similar to those found in non-psychotic patient groups. Thus, work on therapeutic 
alliances in early schizophrenia spectrum disorders requires both specific knowledge on 
the range of symptoms found in these syndromes and knowledge on the general relation 
between interpersonal aspects of personality and the alliance. This is of considerable 
importance, in order to inform clinicians’ alliance enhancing efforts in the early course 
of treatment, as it may serve to prevent drop-out and optimize compliance and outcome. 
Overall this thesis has given empirical support to the relevance that good quality 
working alliances can in fact be achieved in the early phase of schizophrenia spectrum 
disorders, and that a fair degree of agreement on this alliance can be achieved between 
patient and therapist. The thesis has further pointed to the relation between active 
psychotic symptoms (positive and excitative), cognition and patients availability to 
treatment (making- and showing up for appointments) in the early phase of illness
Taken together, these findings state the importance of utilizing the opportunity for early 
treatment gains, and may improve therapist interventions when providing psychosocial 
treatment to patients with early schizophrenia spectrum disorders. 
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Abstract
Background: The therapeutic alliance is related to better course and outcome of 
treatment in schizophrenia. This study explores characteristics of the therapeutic 
alliance in early schizophrenia spectrum disorders including the agreement between 
patient and therapist alliance ratings. Methods: Forty-two patients were assessed with 
demographic, neurocognitive and clinical measures including the Positive and Negative 
Syndrome Scale (PANSS). Therapeutic alliance was measured with the Working 
Alliance Inventory – short form (WAI-S). Results: Patient WAI-S total scores were 
predicted by age and PANSS excitative symptoms. Therapist WAI-S total scores were 
predicted by PANSS insight. Patient and therapist WAI-S total scores were moderately 
associated. Neurocognition was not associated with working alliance. Conclusion: 
Working alliance is associated with specific demographic- and symptom characteristics 
in patients in the early treated phase of schizophrenia spectrum disorders. Patients agree 
more with their therapists on the total quality of the working alliance in the early phase 
of illness. Findings highlight aspects that may increase therapists’ specificity in use of 
alliance enhancing strategies. 
Keywords: 
Schizophrenia; alliance; symptom; psychosocial treatment; agreement.
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Background
Schizophrenia spectrum disorders present with disabling psychiatric symptoms. Most 
patients also have a broad range of difficulties in social and occupational functioning
and extensive, long term need for health care services. Inadequately treated patients risk 
a poorer prognosis and a poorer quality of life [1]. A recent meta-analysis [2] however 
indicates a drop-out rate of 13% for psychosocial treatment in schizophrenia spectrum 
disorders.   It is thus important to uncover factors that have impact on the quality- and 
outcome of treatments.  Low engagement with treatment, as assessed by the Service 
Engagement Scale (SES) [3], is associated with several patient related factors, ranging 
from childhood physical abuse, lack of knowledge of consumer rights and the specific 
personality traits of agreeableness and neuroticism [4] to clinical symptoms (PANSS 
positive and excitative symptoms) and neurocognitive measures (conceptualization) [5]. 
Service engagement is also closely associated with the therapeutic alliance [4].
The therapeutic alliance is widely recognized as a common therapeutic factor, which is 
critical for treatment success across different treatments and patient groups [6]. Authors 
use different terms to describe this alliance,  however the terms most often used are the 
therapeutic-, helping- or working alliance; the latter referring to Bordin’s [7]
formulation of a therapeutic relationship defined by the level of agreement on the tasks 
and goals of therapy, as well as the development of a personal bond between patient and 
therapist.
Several studies show that the therapeutic alliance also is important in schizophrenia, and 
related to important aspects of treatment such as better compliance with medication, 
lower drop-out rates, fewer rehospitalizations, improved symptom levels, and better 
outcomes [8-11]. Interest has over time turned towards more in-depth examination of 
factors that can influence the quality of the therapeutic alliance, including  the degree of 
shared opinion between patient and therapist regarding the quality of the alliance [12-
16]. 
Initially, the idea of a functional working alliance could appear at odds with the 
perception of patients with schizophrenia suffering from reality distortion, or having 
lack of insight into their disorder.  Results from schizophrenia spectrum studies have 
here been somewhat conflicting, in that some have found that the level of psychotic 
symptoms is associated with lower patient ratings of the alliance, whereas others have 
not [13, 17, 18]. Higher levels of insight seems with one exception only [19] to be 
consistently associated with higher patient ratings of the therapeutic alliance [13, 15, 
17], and in one study also with therapist rated alliance [17]. In addition, therapists seem 
to report higher ratings of their alliance with patients who are presenting better social 
abilities [11, 12, 17] than those who do not. While neurocognitive factors have been 
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shown to influence the level of service engagement, there are limited reports of their 
relation to working alliance. A small study of twenty-four patients with chronic 
schizophrenia spectrum disorders, found that poorer verbal memory was associated with 
better patient ratings of working alliance, while better therapist ratings were associated 
with better visuo-spatial reasoning [20].
Results from studies investigating patients’ and therapists’ agreement about the quality 
of the therapeutic alliance have been mixed; where some report a significant association 
between their ratings [17, 18, 20, 21] and others do not [12, 15, 22]. Some studies 
however indicate that patients give higher ratings than the professional regarding the 
level of alliance [15, 17, 18, 22, 23] while others report no significant difference 
between patient and therapist scores [19].
The main body of studies have investigated the therapeutic relationship in the context of 
specific treatments, including cognitive-behavioural therapy (CBT) and cognitive 
remediation therapy (CRT) [11-13, 15, 19, 21]. Most studies have so far investigated 
samples of patients with a relative long duration of illness, where the quality of the 
working alliance may be influenced by negative outcomes or previous treatment 
failures. There are a very limited number of studies investigating the therapeutic 
alliance in early psychosis, i.e. without the possible confounding influences of previous 
therapeutic experiences. One study reported that the therapeutic alliance mediated the 
apparent age effect on outcome in a study of CBT in first episode patients, but without 
reporting descriptive data on the actual alliance itself [24]. One study of working 
alliance in early psychosis examined first episode patients engaged in group therapy 
only [21] thus limiting generalizability of their results to other treatment settings. A 
previous study from the latter group is to our knowledge the only one that reports on 
correlates to the level of therapeutic alliance in first episode patients engaging in
individual treatment relations, and finding that friendship, leisure activates, quality of 
life, levels of insight, and medication side effects predicted 22% of the variance in the 
levels of patients’ working alliance [25] where the latter three were negatively 
associated with better alliances.  The study did however, not report on therapist ratings 
of the alliance and the association between patients’ and therapists’ reports. Omitting 
therapist scores leaves out valuable information concerning to what extent patients and 
therapists share opinion the nature of their therapeutic relation.
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The aim of the present study is thus to explore characteristics of the working alliance in 
patients in the early treated phase of schizophrenia spectrum disorders, with the aim of 
answering the following questions: 
To what extent do demographic, clinical and cognitive characteristics influence 
patients’ and therapists’ reports of working alliance?  
To what extent is there an association between patients’ and therapists ratings of the 
therapeutic alliance? 
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Methods
Design
Subjects were recruited from  out- and inpatient services at the Division of Psychiatry, 
St. Olav’s Hospital,  Trondheim University Hospital, Norway (catchment area of 
approximately 230 000 inhabitants over the age of 18) as a part of the Thematically 
Organized Psychosis (TOP) research study [5]. The study was cross-sectional and 
patients were included consecutively in the period from December 2006 to November 
2011. The study was approved by the Regional Committee for Medical Research Ethics 
and the Norwegian Data Inspectorate. Participants' written informed consent was 
obtained according to the Declaration of Helsinki. 
Procedure
Clinical psychologists and psychiatrists were trained specifically in the use of the 
applied measures and completed the assessments. All diagnoses, symptom assessments 
and scorings were then reevaluated and discussed with the first author and consensus 
scorings applied. The first author had completed the comprehensive training program 
used by the TOP study (based on the program used at the Semel Institute for 
Neuroscience and Human Behavior at the University of California, Los Angeles, 
UCLA). The TOP study’s program show good diagnostic reliability both towards gold 
standard training videos and for blinded expert scorings of randomly selected case 
vignettes from the actual sample. The inter-rater reliability of PANSS subscales for the 
training program were in the range of 0.73 – 0.82 (Intra Class Coefficient) (see [26] and 
[27] for details).
Working Alliance self-report forms were filled in by patients and therapists separately 
the same week or as soon as possible after symptom assessments, and placed in closed 
envelopes. Therapists were the patients’ primary treating psychiatrist or psychologist at 
the hospital. All diagnoses and symptom assessments were thus blind to working 
alliance scores. 
Subjects
The inclusion criteria were: 1) age 18 - 65 years and 2) meeting the DSM-IV criteria for 
a schizophrenia spectrum psychosis; including schizophrenia, schizophreniform 
disorder, schizoaffective disorder, and delusional disorder 3) having the capability for 
supplying written informed consent and 4) language abilities to complete the 
neurocognitive test battery. Exclusion criteria for patients were: a history of 
moderate/severe head injury, neurological disorders or mental retardation (IQ less than 
70), in addition to comorbid cluster A or B personality disorder according to DSM-IV 
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(determined by clinical consensus based on evaluation of the DSM-IV criteria). Patients 
were eligible for inclusion up to two years following the start of their first episode (i.e. 
meeting the criteria for a schizophrenia spectrum psychosis as defined above) and up to 
one year after their first meeting with their current therapist. Of those who consented, 
two were found ineligible due to longer duration of illness than accepted by inclusion 
criteria, two because of inadequate language abilities for completing the neurocognitive 
test battery, one were diagnosed with bipolar disorder, one withdrew the consent, and 
one dropped out without actively withdrawing consent.
The study thus includes 42 subjects; 36 (85.7%) with schizophrenia, 3 (7.1%) with 
schizoaffective disorder, and 3 (7.1%) with delusional disorder; 28 (66.7%) men and 14 
(33.3%) women; 28 (66.7%) were inpatients and 14 (33.3%) were outpatients at 
inclusion. Thirty three (78.6%) were prescribed antipsychotic medication; four (9.5%) 
were prescribed mood stabilizers, one (2.4%) had antidepressive medication only, and 
eight (19%) did not use any psychotropic drugs. Mean duration of current antipsychotic 
treatment was 4.8 (± 6.7) months (min 0.25, max 36). Eight (19%) met DSM-IV criteria 
for substance abuse, six (14.3%) for substance dependence, one met criteria for alcohol 
abuse (2.4%) and five (11.9%) for alcohol dependence.  On average, subjects had 2.8 (±
3.6) psychiatric hospitalizations (min 0, max 18) a mean age of 27.5 (± 5.6) years (min 
20, max 51) and 11.8 (± 1.9) years of education (min 9, max 17).
Measurements
Clinical assessment
Diagnoses were established by use of the Structured Clinical Interview for Diagnostic 
and Structural Manual of Mental Disorders (SCID), fourth version [28]. Symptoms 
were assessed with the Positive and Negative Symptom Scale (PANSS) [29] after 
interview with the Structural Clinical Interview for the Positive and Negative Symptom 
Scale (SCI-PANSS) [30]. For the present study, we used a five factor solution for 
scoring scale components derived from a first episode sample [31]; The PANSS Positive 
factor consists of the PANSS items P1 Delusions, P3 Hallucinatory behavior, P5 
Grandiosity, P6 Suspiciousness/persecution, G9 Unusual thought content, and G12 
Lack of judgment and insight; The PANSS Disorganized factor consists of the PANSS 
items P2 Conceptual disorganization, N5 Difficulty in abstract thinking, N7 Stereotyped 
thinking, G5 Mannerisms and posturing, G10 Disorientation, G11 Poor attention, and 
G15 Preoccupation; The PANSS Negative factor consists of the PANSS items N1 
Blunted affect, N2 Emotional withdrawal, N3 Poor rapport, N4 Passive/apathetic social 
withdrawal, N6 Lack of spontaneity and flow of conversation, G7 Motor retardation, 
and G16 Active social avoidance; The PANSS Depressive/anxious factor consists of the 
PANSS items G1 Somatic concern, G2 Anxiety, G3 Guilt feelings, G4 Tension, and G6 
Depression; The PANSS Excitative factor consists of the PANSS items P4 Excitement, 
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P7 Hostility, G8 Uncooperativeness and G14 Poor impulse control. To simplify 
comparisons with previous research, we chose to focus on psychotic and general 
psychiatric symptoms, including insight (item G12) as measured by the PANSS, and a 
set of relevant demographic variables (psychotic and affective symptoms, age, 
education and number of months on antipsychotic medication).  Insight was measured 
with the PANSS item G12 (“Failure to recognize past or present psychiatric illness or 
symptoms, denial of need for psychiatric hospitalization or treatment, decisions 
characterized by poor anticipation of consequences, and unrealistic short-term and 
long-range planning.”).
Neurocognitive measures
Neurocognitive functioning was assessed by use of a standardized neuropsychological 
test battery comprised of tests chosen for their relevance to schizophrenia spectrum 
disorders. The tests were administered in a fixed order by trained clinical psychologists. 
The tests consisted of: Current general intellectual ability was estimated by use of four 
subtests from the Wechsler Adult Intelligence Scale (WAIS-III): Similarities, 
Vocabulary, Block design and Matrixes [32]. Verbal memory was measured by the 
California Verbal Learning Test II (CVLT-II) [33]. The test requires the patient to 
verbally recall (in five consecutive immediate recall trials) from a list of 16 words read 
by the test administrator, as many words as possible. Verbal recall of the same 16 words 
was assessed with the 30 min delayed recall. Executive functions were measured by the 
Wisconsin Card Sorting Test Computer Version 4-Research Edition (WCST: CV4) 
[34]. Attention was measured by Conners Continuous Performance Test II (CPT-II) 
[35].
Working Alliance - Short Version – Client and Therapist Forms
Therapeutic alliance was assessed with the Working Alliance Inventory - Short Version 
(WAI-S) [36], a 12-item short version of the Working Alliance Inventory (WAI) [37].
The inventory is based on Bordins’ [38] formulation of the working alliance consisting 
of the therapeutic bond between client and therapist as well as their agreement on 
therapeutic goals and the tasks attended to in treatment. The WAI is a statement based 
self-report measure with corresponding therapist and patient versions. Each statement is 
answered on a seven point scale by indicating to what degree the statement is true (1= 
never, 2= rarely, 3= now and then, 4= sometimes, 5= often, 6= very often, 7= always). 
The WAI-S consists of twelve items of which two statements (item 4 and 10) are 
formulated as negations and scores reversed before computing total scores. Initial 
reliability analyses confirmed high internal consistency for WAI-S therapist and patient 
total scores, and therapist and patient sub scores for Tasks, Goals and Bond, with 
Chronbach’s Alpha ranging from .69 to .89.  
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Statistical analyses
Statistical analyses were performed by use of the Statistical Package for the Social 
Sciences, version 19 [39]. Because not all relevant variables were normally distributed 
we used nonparametric tests in the bivariate analyses (Spearman’s correlations and 
Mann-Whitney U test for two independent samples). Tests were two-tailed and had a 
pre-set level of significance of 0.05. Multiple linear regression analyses with patients’ 
and therapists’ total WAI-S scores were performed to assess the individual contribution 
from variables with a significant bivariate association to the WAI S total and sub scores. 
Model fit was evaluated through examination of residual plots. Due to administrative 
error one PANSS item G12 (measuring insight) as well as one patient and two therapists 
working alliance assessment forms were missing. Also, due to individual difficulties in 
completing all tests, CVLT-II and WCST was not administered for one patient and 
CPT-II for two patients. All missing scores were replaced by mean scores for the total 
sample in our analyses.
Results
There were no gender differences, or differences between inpatients and outpatients in 
neither patients’ nor therapists’ WAI-S total or sub scores. Patients with longer 
education reported higher levels of WAI-S total and treatment tasks- and goals score.  
Older patients reported higher levels of the treatment tasks score (Table 2).  There were 
no associations between demographic patient characteristics and therapists scores
(Table 2).  
Higher scores (i.e. higher symptom loads) for the PANSS Positive factor, and Excitative 
factor was associated with  lower patients’ WAI-S total scores,  in addition to lover 
levels of several sub scores (Table 2).  High scores for the PANSS Negative factor and 
Excitative factor was also associated with lower levels of therapists’ WAI-S total 
scores, in addition to several sub scores (Table 2).  The level of PANSS insight (G12) 
was not associated with patients’ scores but negatively associated with WAI-S therapist 
total scores in addition to several sub scores (Table 2). There were no association 
between any of the neurocognitive scores and patients’ or therapists’ WAI-S ratings.   
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Table 1.
Descriptive statistics for psychotic symptoms, neurocognition and working alliance. 
Mean 
± SD
Min Max Median
PANSS
Total score 66.9 ± 15.6 49 115 63.0
POSITIVE
(P1, P3, P5, P6, G9, G12)
17.0 ± 5.6 6 33 16.0
DISORGANIZED
(P2, N5, N7, G5, G10, G11, G15)
13.1 ± 4.3 7 24 12.0
NEGATIVE
(N1, N2, N3, N4, N6, G7, G16)
15.4 ± 6.1 7 28 15.0
DEPRESSIVE/ANXIOUS 
(G1, G2, G3, G4, G6)
13.4 ± 4.5 5 23 13.5
EXCITATIVE
(P4, P7, G8, G14)
5.9 ± 2.2 4 13 6.0
Item G12 insight 2.3 ± 1.3 1 6 2.2
WAI-S Patient
total score 61.6 ± 11.1 31 79 64.0
tasks score 20.4 ± 4.1 8 28 20.2
goals score 20.9 ± 3.8 12 27 21.5
bond score 20.3 ± 4.9 7 28 20.7
WAI-S Therapist
total score 62.4 ± 7.7 38 80 62.2
tasks score 20.4 ± 3.4 12 28 20.2
goals score 20.6 ± 3.0 10 26 20.8
bond score 21.5 ± 2.6 15 26 21.5
WAIS-III (scaled scores)
Vocabulary 9.71 ± 2.6 6 18 9.5
Similarities 9.74 ± 3.3 5 18 9.0
Block design 11.43 ± 3.6 5 19 11.0
Matrixes 11.48 ± 3.3 4 18 12.0
CVLT II (z-score)
Long delay free recall -0.42 ± 1.5 -4 1.5 -0.2
WCST (T-scores)
Perseverative responses 45.49 ± 7.9 21 59 45.2
Perseverative errors 44.73 ± 8.2 20 63 45.0
CPT-II (T-scores)
Omissions 54.54 ± 12.8 40.9 101.1 49.9
Comissions 59.44 ± 11.1 38.1 79.9 61.6
WAI-S = Working Alliance Inventory, short form; PANSS = Positive and Negative Syndrome Scale; SD = Standard Deviation; 
WAIS-III = Wechsler Adult Intelligence Scale III; CVLT II = California Verbal Learning Test II; WCST = Wisconsin Card Sorting 
Test; CPT-II = Conners Continuous Performance Test II
SUBMITTED ARTICLE
11
Table 2. 
Spearman’s correlations (rho) between WAI-S patient/therapist total- and sub scores and clinical 
symptoms, insight and patients total years of education. Significant correlations in bold numbers.
WAI-S patient  
Spearman’s rho
WAI-S therapist
Spearman’s rho
Total Tasks Goals Bond Total Tasks Goals Bond
PANSS 
Positive -.279 -.262 -.358* -.128 -.137 -.064 -.129 -.162
Disorganized -.263 -.290 -.193 -.177 -.143 -.107 -.186 -.053
Negative -.141 -.290 -.193 -.177 -.338* -.350* -.188 -.203
Depressive/anxious -.059 -.124 -.126 -.013 .041 .096 .126 -.119
Excitative -.337* -.496** -.147 -.306* -.225 -.127 .016 -.398** 
Insight
PANSS Item G12 -.089 -.040 .016 -.159 -.394** -.349* -.417** -.259
Age .244 .323* .104 .242 -.020 -.091 -.130 .175
Education
Total years .414** .394* .323* .303 .021 -.025 -.101 .174
WAI-S = Working Alliance Inventory, short form; PANSS = Positive and Negative Syndrome Scale (Positive=P1, P3, P5, P6, G9, 
G12; Disorganized=P2, N5, N7, G5, G10, G11, G15; Negative=N1, N2, N3, N4, N6, G7, G16; Depressive/anxious=G1, G2, G3, 
G4, G6; Excitative=P4, P7, G8, G14). *=p<.05 **=p<.01
Multivariate linear regression analyses indicated that the best model explaining the level 
of patients’ WAI-S total score was the patient’s age and level of excitative symptoms, 
which explained 23% of the observed variance. For therapist WAI-S total scores, the 
regression analysis indicated that only insight (PANSS item G12) had a statistical 
significant influence and could explain 17% of the observed variance (table 3). 
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Table3. 
Multivariate linear regression analyses of patients and therapists’ WAI-S total scores. 
Model summary Partial effects
Adj. R2 R2 F ȕ t p 95% CI
Lower Upper
Patient WAI-S total 0.19 0.23 5.7
Age 0.36 2.55 0.015 0.15 1.29
+ PANSS excitative -0.28 -2.00 0.052 -2.85 0.01
Therapist WAI-S total 0.14 0.17 7.9
Insight 
(PANSS G12)
-0.41 -2.81 0.008 -4.05 -0.66
WAI-S = Working Alliance Inventory, short form; PANSS = Positive and Negative Syndrome Scale
There were no differences (numerical or statistical) in the mean level of patient and 
therapist WAI-S total scores (ES 0.09), but with marginally larger variation in patient 
ratings (Table 1). Patients and therapist’s WAI-S total scores were statistically 
significantly associated (Table 4) and also had moderate degrees of association on the 
sub score level (table 4). An exploratory regression analysis with  patients’ WAI-S total 
score as dependent including therapist’ WAI-S total score as an  independent variable at 
the last step of the analysis, indicated that neither age, PANSS Excitative factor nor 
PANSS Insight (G12) mediated or moderated their level of association.  
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Table 4. 
Spearman’s correlations (rho) between WAI-S patient and WAI-S therapist total- and sub scores. 
Significant correlations in bold numbers.
WAI-S patient  
Spearman’s rho
Total Tasks Goals Bond
WAI-S
therapist
Spearman’s rho
Total .394** .354* .342* .321*
Tasks .372* .305* .262 .357*
Goals .237 .171 .239 .162
Bond .409** .426** .365* .298
WAI-S = Working Alliance Inventory, short form. *=p<.05 **=p<.01
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Discussion
The main finding was that that the patient’s age and level of excitative symptoms were 
the primary predictors of the patients’ ratings of working alliance, while level of insight 
was the strongest predictor of therapists’ ratings. There was no indication of any 
associations between neurocognitive factors and working alliance. This has been 
suggested, but not consistently found in previous studies from more chronic groups [12, 
13, 15, 17, 19, 20]. Overall, there was a moderate degree of shared opinion between 
patient and therapist ratings of the quality of the working alliance, which was not 
influenced by the previously identified predictors of patients’ and therapists’ alliance 
ratings. This may be an expression of the unique relational aspect of the working 
alliance, or pertain to other mediating variables that were possibly not included in the 
current study. 
The association between excitative symptoms and patients’ experience of global 
working alliance with therapists seems reasonable from a clinical perspective, as 
excitement, hostility, uncooperativeness and poor impulse control are behaviors 
contingent with negative relational experiences. Such an association has also been 
described in older groups of patients with schizophrenia spectrum disorders [19] 
although not consistently [12]. The multivariate regression analyses indicated that the 
bivariate association between total years of education and patient total alliance scores 
was mediated through age differences. This is in line with findings from older and more 
chronic patients, who do not indicate any relationships between education and alliance 
[13].
The current study does not  reproduce previous findings from more chronic patients 
samples showing statistically significant associations between  working alliance and 
positive (psychotic) symptoms, negative symptoms and  levels of  insight [13, 15, 17]. 
While the correlation coefficients for positive and negative symptoms reached sub 
threshold level for statistical significance, the level of association was consistently low 
for insight. When contrasted with the above mentioned previous research, the present 
findings suggest that there may be a qualitatively different pattern of associations 
between patient characteristics, insight and working alliance in the early treatment of 
the schizophrenia spectrum disorders relative to patients with longer duration of their 
illness. Insight (i.e. the quality of patient awareness and understanding of own 
psychiatric condition and degree of withdrawal) was the only factor influencing the 
therapist scores.  Thus, therapists should be aware of how this may blur their perception 
of the quality of the therapeutic relation as the patient sees it,  and also of  the effect of 
lack of insight on his/her personal experience of the cooperation and bond with the 
patient in early phases of treatment. Both aspects could possibly exert a secondary effect 
on therapist behaviors.
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Looking at the WAI’s subscale level, patient and therapist ratings of their relational 
bond were uniquely associated with excitative symptoms, suggesting that the more 
unstable, hostile and uncooperative symptoms are specifically associated with both 
parts’ experience of a poorer relational bond. Still, patient and therapist ratings of the 
relational bond are not consistently associated with each other, suggesting that other 
factors also influence bond scores as well. Thus, the data supports the notion that the 
therapeutic alliance is a complex phenomenon. Patient and therapist ratings of 
agreement on treatment tasks showed the same patterns of association as their working 
alliance total scores, perhaps illustrating the higher impact of these two subscales on the 
working alliance total score. 
Patient ratings of less agreement on treatment goals were differentially associated with 
patients having shorter education and more positive psychotic symptoms, i.e. delusions, 
hallucinatory behavior, grandiosity, suspiciousness/persecution, unusual thought 
content, and lack of judgment and insight, in agreement with previous findings [13].
Therapist ratings of less agreement on treatment goals were solely associated with 
patients showing poorer judgment and insight. These results seem to mirror a well-
known challenge in clinical work, when negotiating agreement on treatment goals with 
patients and there is little or no shared or common perception of reality: The delusional 
or hallucinating patient experiences the therapist as working towards different goals as 
him or herself, and the therapist who struggles with establishing joint goals experiences 
the patient as presenting with lack of insight. One could argue that due to lack of shared 
reality, differential patterns of factors that are associated with patient and therapist 
perspectives on the working alliance are to be expected in therapeutic work with 
psychotic patients.
In the present study WAI-S total score levels and distributions for patients and 
therapists were fairly high and comparable to those reported in other studies of 
schizophrenia spectrum samples using the same scale [13, 17, 19]. There was a 
moderate association between patient and therapist global ratings of the Working 
alliance, but with a higher concordance in alliance total scores between patients and 
therapists than in previous studies [12, 13, 15, 18, 19]. Multivariate linear regression 
analyses indicated that the association between patient and therapist working alliance 
total scores were not moderated by other predictors of the total scores. The higher 
degree of shared opinion on the Working alliance found in this study compared to 
previous studies possibly reflect a better quality of the therapeutic alliance with patients 
in early phases of schizophrenia spectrum disorders as compared to older patients with 
longer duration or more chronic courses of illness. If so, this adds weight to the 
importance of the early psychosocial treatment for patients with these disorders.
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On the sub scale level, the differential characteristics of patient and therapist 
perceptions of the alliance were reflected in that both goal scores and bond scores were 
unrelated, while tasks scores were moderately associated. The strongest subscale 
associations were between therapist bond scores and patient tasks and goals scores, 
possibly indicating that patient experience of agreement on treatment tasks and goals 
and therapist experience of a stronger relational bond are aspects that are mutually 
dependent on each other. 
Limitations
The study sample was of moderate size which may limit generalizability. Participating 
patients were not part of a standardized treatment program, but assessed in a naturalistic 
treatment setting at the hospital psychiatric department. This lessened the possibility to 
standardize timing of assessments in detail, and theoretically increased the number of 
possible confounding variables.
Conclusion
Patients and therapists qualitative experience of the Working alliance is associated with 
specific, but different patient characteristics in the early years of schizophrenia spectrum 
disorders. These may be phase specific characteristics associated with the quality of the 
early alliance. Patients in the early phase share opinion with their therapists on the 
quality of the Working alliance to a higher degree than patients in later phases of illness. 
These findings highlight the importance of utilizing the opportunity for early treatment 
gains, and may increase therapists’ specificity in their alliance enhancing strategies. 
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Abstract
Background: The quality of the therapeutic alliance is associated with engagement in-
and thus important with the outcome of- treatment in schizophrenia. In non-psychotic 
disorders, general personality traits and individual patterns of interpersonal problems 
have been linked to the formation and quality of the therapeutic alliance. The role of 
these factors in relation to therapeutic alliance has not previously been explored in 
schizophrenia spectrum disorders.
Aim: To investigate associations between personality traits, interpersonal problems and 
the quality of the therapeutic alliance in early schizophrenia spectrum disorders. 
Methods: Demographic and clinical characteristics including Positive and Negative 
Syndrome Scale (PANSS) scores were assessed in 42 patients. Personality traits and 
interpersonal problems were assessed with the NEO Five factor Inventory (NEO-FFI) 
and the circumplex model of the Inventory of Interpersonal Problems (IIP-64C).
Therapeutic alliance was measured with the Working Alliance Inventory – short form 
(WAI-S). 
Results: Patient WAI-S scores were predicted by IIP-64C Submissive/Hostile 
interpersonal problems, age and PANSS excitative symptoms. Therapist WAI-S scores 
were predicted by NEO-FFI Agreeableness and the PANSS insight item.
Conclusion: Core traits of personality and dimensions of interpersonal problems are 
associated with both patients’ and therapists’ perceptions of the quality of the working 
alliance.
Key words: Schizophrenia; alliance; interpersonal; psychosocial treatment; personality.
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Introduction 
Poor patient engagement in treatment is an obstacle to treatment success in 
schizophrenia spectrum disorders. Drop-out from treatment represents a major challenge 
not only to psychopharmacological but also to psychosocial treatments [1, 2]. Poor 
engagement with treatment in psychotic disorders has been found to be associated with 
patient related factors, including childhood physical abuse, lack of knowledge of 
consumer rights, clinical symptoms (PANSS positive and excitative symptoms),
specific personality traits (NEO-FFI neuroticism and agreeableness), neurocognitive 
measures (conceptualization) [3] as well as to the quality of the therapeutic alliance
itself [4].
Across patient groups and treatments, the therapeutic alliance is regarded a common 
therapeutic factor important to successful treatment outcomes [5]. A commonly used 
formulation of the therapeutic alliance is Bordin’s definition of the “Working Alliance”
[6] as comprised of the quality of the personal bond between patient and therapist, and 
the degree of agreement between the two on the tasks and goals of therapy. The 
therapeutic alliance is also identified as important in schizophrenia both for engagement 
and outcome of treatment [7-12]. This warrants identification of factors that may 
influence the quality of the therapeutic alliance [7, 13-16]
Most studies on the therapeutic alliance in schizophrenia spectrum samples have 
focused on the predictive value of characteristics inherent to the disorder itself,  such as 
psychotic symptoms [9, 17, 18], insight [9, 14, 16, 19] and social disabilities [7, 11, 16].
The most consistent results have been found for insight, in the direction that high insight 
is positively associated with patient’s ratings of a good working alliance, and good 
social abilities with therapist’s ratings of a good working alliance. Linking insight to 
aspects of metacognition, some argue that the mutual agreement on goals of therapy 
needed to form a working alliance may depend on the ability to reflect upon one’s own 
thinking and the thinking of others [20].
Alliance research in this patient group has however mainly been conducted as part of 
research studies on standardized treatment programmes (e.g. cognitive-behavioural 
therapy (CBT) and cognitive remediation therapy (CRT)) [7, 9, 11, 12, 14, 19, 21];
possibly limiting generalizability to other treatment settings. Until now, studies have
also primarily explored the therapeutic alliance in patient samples with long duration of 
illness and multiple previous hospitalizations; factors that may affect the alliance
through negative treatment experiences.
The number of studies in early psychosis is very limited.  However, one early psychosis
study [22] found that better quality of life, better insight and  medication side effects
were associated with lower- and  good levels of friendship and leisure activities were 
associated with higher patient’s working alliance ratings, together accounting for 22% 
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of the variance. Another study, investigating group therapy for early psychosis [21]
reported that a social support subscale termed “attachment” was predictive of patient 
rated alliance, explaining 18% of the observed variance. Finally, a study using the 
Psychotherapy Status Report [8], reported that therapists found it more difficult to 
engage young patients in cognitive- behavioural therapy (CBT) or supportive therapy 
than older patients. [23].
Across theoretical models, methods and groups of patients, the interpersonal aspect 
remains a common element to the different forms of psychotherapy and psychosocial 
treatments [24]. Relational measures can be direct measures of relational behavior or 
indirect measures of individual characteristics that influence how a person feels about 
and relates to others [24, 25]. Core traits of personality and patterns of interpersonal 
problems are examples of individual characteristics with considerable relational impact.
In non-psychotic axis I psychiatric disorders [26] and axis II borderline personality 
disorder [27], aspects of general personality traits are found to be associated with the 
formation of the therapeutic alliance. It has also been shown that the degree of 
interpersonal problems predict the quality of the therapeutic alliance [28-31].
It is  documented that basic traits of personality, as defined by the five factor model of 
Costa and McCrae [32, 33],  are applicable and stable also in patients with 
schizophrenia spectrum disorders [34-38]. There are also consistent reports that patients 
with schizophrenia score higher on neuroticism and lower on conscientiousness relative 
to other, non-psychotic patient groups and to healthy control samples, and that a higher 
level of neuroticism is associated with higher levels of positive psychotic symptoms.  
There are also reports of low scores on extraversion, agreeableness and openness [38, 
39] but with mixed findings regarding the relation of these personality factors and 
symptomatology [34, 40].   To our knowledge, the role of personality in relation to the 
therapeutic alliance has not been explored in schizophrenia spectrum disorders. This is  
of importance, as a recent study of patients in the early treated phases of psychotic 
disorders found that  higher levels of neuroticism and lower levels of agreeableness, 
together with childhood physical abuse, lack of knowledge concerning consumer rights 
and the quality of therapeutic alliance, accounted for 31% of the variance in patients’ 
engagement with treatment services [4].
In a previous report from the current study [41] we found that patient ratings of working 
alliance, as measured by the Working Alliance Inventory – Short (WAI-S), were 
predicted by patient age and the level of excitative symptoms as measured by the 
Positive and Negative Syndrome Scale (PANSS);  while therapist ratings were predicted 
by the level of PANSS insight. No associations were found between any neurocognitive 
factors and the working alliance. 
The aim of the present part of the study is to explore if personality (as measured by the 
NEO-FFI) and dimensions of interpersonal problems (as measured by the IIP-64C) in 
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patients in the early treated phase of schizophrenia spectrum disorders are associated 
with patients’ and therapist’ experience of the working alliance.
2. Materials and method
2.1 Design and sample
Subjects were included consecutively at the Division of Psychiatry, St. Olav’s Hospital, 
Trondheim University Hospital, Norway (catchment area of approximately 230 000 
inhabitants over the age of 18) during the period from December 2006 to November 
2011. Both out- and inpatient services were included. Written informed consent was 
obtained from participants according to the Declaration of Helsinki. The study is an 
affiliated research project to the ongoing Thematically Organized Psychosis (TOP) 
study at the University of Oslo, Norway, and was approved by the Regional Committee 
for Medical Research Ethics and the Norwegian Data Inspectorate. 
Inclusion criteria were: age 18 - 65 years, meeting the DSM-IV criteria for a 
schizophrenia spectrum psychosis (including schizophrenia, schizophreniform disorder, 
schizoaffective disorder, and delusional disorder) having adequate language abilities to 
complete the neurocognitive test battery, and having the ability to supply written 
informed consent. Patients were eligible for inclusion no more than two years following 
the first time they met the criteria for a schizophrenia spectrum psychosis (as defined 
above) and no more than one year after first establishing contact with their current 
therapist. Exclusion criteria were: comorbid cluster A or B personality disorder 
according to DSM-IV criteria, neurological disorders or mental retardation (IQ less than 
70), or a history of moderate/severe head injury. 
Both inpatients and outpatients were in general attending therapeutic sessions with their 
therapist once a week. At the hospital, non-pharmacological treatment for schizophrenia 
spectrum disorders is routinely given within an eclectic framework of interpersonal 
cognitive-behavioral theories.
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Table 1. Sample description:
Min Max
Age (Mean ± SD) 27.5 (± 5.6) 20 51
Education (Mean ± SD) 11.8 (± 1.9) 9 17
Gender N (%)
Male 28(66.7)
Female 14(33.3)
Diagnosis N (%) 42 (100)
Schizophrenia 36 (85.7)
Schizoaffective disorder 3 (7.1)
Delusional disorder 3 (7.1)
Inpatients N (%) 28 (66.7)
Outpatients N (%) 14 (33.3)
Number of psychiatric hospitalizations
(Mean ± SD) 2.8 ± 3.6
Medication N (%)
Antipsychotic 33 (78.6)
Mood stabilizers 4 (9.5)
Antidepressive only 1 (2.4)
No medication 8 (19.0)
Substance abuse N (%) 8 (19.0)
Substance dependence N (%) 6 (14.3)
Alcohol abuse N (%) 1 (2.4)
Alcohol dependence N (%) 5 (11.9)
PANSS (Mean ± SD)                                                  Total score 66.9 ± 15.6 49 115
POSITIVE (P1, P3, P5, P6, G9, G12) 17.0 ± 5.6 6 33
DISORGANIZED (P2, N5, N7, G5, G10, G11, G15) 13.1 ± 4.3 7 24
NEGATIVE (N1, N2, N3, N4, N6, G7, G16) 15.4 ± 6.1 7 28
DEPRESSIVE/ANXIOUS (G1, G2, G3, G4, G6) 13.4 ± 4.5 5 23
EXCITATIVE (P4, P7, G8, G14) 5.9 ± 2.2 4 13
Item G12 insight 2.3 ± 1.3 1 6
WAI-S Patient (Mean ± SD)                                      Total score 61.6 ± 11.1 31 79
tasks score 20.4 ± 4.1 8 28
goals score 20.9 ± 3.8 12 27
bond score 20.3 ± 4.9 7 28
WAI-S Therapist (Mean ± SD)                                 Total score 62.4 ± 7.7 38 80
tasks score 20.4 ± 3.4 12 28
goals score 20.6 ± 3.0 10 26
bond score 21.5 ± 2.6 15 26
IIP-64C raw/ipsated scores (Mean ± SD)
Dominant/Hostile 1.7 / -0.7 ± 1.2
Submissive/Hostile 2.6 / 0.2 ± 1.4
Submissive/Friendly 3.1 / 0.6  ± 1.6
Dominant/Friendly 2.3 / -0.2 ± 1.4
NEO-FFI T-scores (Mean ± SD)
Neuroticism 60.4 ± 10.1
Extraversion 40.0 ± 9.3
Openness 42.4 ± 6.8
Agreeableness 50.0 ± 10.4
Conscientiousness 42.2 ± 8.3
WAI-S = Working Alliance Inventory, short form; PANSS = Positive and Negative Syndrome Scale; IIP-64C = Inventory of Interpersonal 
Problems 64 items Circumplex version; NEO-FFI = NEO Five-Factor Inventory; SD = Standard Deviation.
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2.2 Clinical assessments
The assessments complied with the protocol for the TOP research study. All diagnoses
and assessments were completed by clinical psychologists and psychiatrists trained 
specifically in administration and scoring of the applied measures. A consensus scoring
was then reached through discussion with the first author, who had completed the TOP 
study group’s comprehensive training program which have shown to achieve good 
potential and actual diagnostic reliability (group kappa of 0.77 both towards gold 
standard training videos and for blinded expert scorings of randomly selected case 
vignettes from the actual sample (details available in Ringen et al [42])) and good actual 
reliability for symptom assessments  (Intra Class Coefficient (ICC) in the range 0.73 –
0.82 for the PANSS subscales (details available in Faerden et al [43])). Assessments of 
diagnoses and symptoms were done blind to working alliance scores, as patients and 
therapists separately filled in working alliance self-report forms and placed them in
closed envelopes the same week or as soon as possible after symptom assessments. 
Diagnoses were made by use of the Structured Clinical Interview for Diagnostic and 
Structural Manual of Mental Disorders (SCID), fourth version (APA, 1995). Symptoms 
were assessed with the Positive and Negative Symptom Scale (PANSS) (Kay et al, 
1987) based on the Structural Clinical Interview for the Positive and Negative Symptom 
Scale (SCI-PANSS) (Kay et al, 1991) We here use a five factor solution for scoring 
scale components derived from a first episode sample (Emsley et al, 2003). 
The Working Alliance Inventory - Short Version (WAI-S) [44], a 12-item short version 
of the Working Alliance Inventory (WAI) [45] was applied to assess the therapeutic 
alliance. The WAI is designed to measure Bordins’ [46] concept of the working 
alliance; the therapeutic bond between client and therapist, as well as their agreement on 
therapeutic goals and tasks. The WAI-S is a self-report measure with corresponding 
therapist and patient versions. Twelve statements are rated on a seven point scale 
representing to what degree each statement is true (1= never, 2= rarely, 3= now and 
then, 4= sometimes, 5= often, 6= very often, 7= always). Statements number 4 and 10 
are formulated as negations and scores therefore reversed. Chronbach’s Alpha 
estimating internal consistency in the range from .69 to .89, confirmed good reliability 
for WAI-S therapist and patient total scores, as well as therapist and patient sub scores 
for Tasks, Goals and Bond.
To measure personality traits, the self-report measure NEO-FFI [47] was used. NEO-
FFI is a 60 item short version of the NEO PI-R [47] where the respondent is asked to 
rate statements on a five point scale indicating the degree of agreement with each 
statement (‘strongly disagree’, ‘disagree’, ‘neutral’, ‘agree’, ‘strongly agree’). The 
NEO-FFI assess the five basic traits of personality; Neuroticism, Extraversion, 
Openness, Agreeableness and Conscientiousness. The IIP-64C [48] was used to 
measure eight dimensions of interpersonal problems. The instrument is a self-report 
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measure that asks the respondent to indicate to what degree he or she experience a set of 
64 different behaviors as difficult (39 items) or done too much (24 items) (‘not at all’, ‘a 
little’, ‘moderately’, ‘quite a lot’, ‘a lot’). It yields results on eight dimensions of 
interpersonal problems constituting a circumplex of personality; Domineering (PA), 
Vindictive (BC), Cold (DE), Socially inhibited (FG), Nonassertive (HI), Exploitable 
(JK), Overly nurturant (LM) and Intrusive (NO). It has been suggested that these 
dimensions of interpersonal problems can be represented by two orthogonal dimensions 
indicating dominance versus submissiveness and friendliness versus hostility (figure 1). 
This yields four quadrants of interpersonal problems; Submissive/Hostile (Cold (DE) + 
Socially Avoidant (FG)), Submissive/Friendly (Nonassertive (HI) + Exploitable (JK)), 
Dominant/Friendly (Overly Nurturant (LM) + Intrusive (NO)) and Dominant/Hostile 
(Dominant (PA) + Vindictive (BC)) [24, 49, 50]. Methodological studies on the IIP-64C 
have shown that in addition to the eight dimensions of interpersonal problems, the 
instrument yields a strong general factor, often termed a “complaint dimension” or 
“interpersonal distress factor”. In previous studies this general factor has been linked to 
level of symptoms and negative affect [51]. To separate the effect of severity of distress 
from the relative experience of interpersonal problems statistical ipsation of scores, i.e. 
indicating scores in terms of their deviation from the individuals mean IIP-64C score is 
used; the ipsated scores thus indicate to what extent each type of interpersonal problem 
is experienced as more troublesome to the person relative to other types of interpersonal 
problems [49]. Due to administrative error five IIP-64 and NEO-FFI forms as well as 
one patient and two therapists working alliance assessment forms were missing. 
Missing scores were replaced by mean scores for the total sample in our analyses.
2.3 Statistical analyses
The Statistical Package for the Social Sciences, version 19 [52] was used for statistical 
analyses. IIP-64C scores were ipsated by subtracting individual IIP-64C total mean 
score from individual sub scale scores. IIP-64C quadrant scores were computed by 
summing the relevant two of the original eight-scale scores in separate procedures for 
raw and ipsated scores. Bivariate analyses including WAI-S scores were performed by 
use of nonparametric tests (Spearman’s correlations and Mann-Whitney U test for two 
independent samples) because alliance scores were not normally distributed. Other 
bivariate analyses were performed by use of parametric tests (Pearson’s correlations and 
T-tests). Tests were two-tailed and had a pre-set level of significance of 0.05. 
Hierarchical linear regression analyses were performed to assess the individual 
contribution to patients’ and therapists’ total WAI-S scores of variables that had a
significant bivariate association to the WAI-S total scores. In addition to measures of 
personality and interpersonal problems, patient’s age and PANSS excitative symptoms 
were thus included in the analysis of WAI-S patient total scores. In the same way, 
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PANSS item G12 Insight was included in the analysis of WAI-S therapist total scores 
[3]. Model fit was evaluated through examination of residual plots. 
3. Results
Patients’ scores for this sample differed significantly from the normative sample mean 
for all NEO-FFI personality traits, with the exception of Agreeableness. Patients scored 
significantly higher on NEO-FFI Neuroticism, and lower on Extraversion, Openness
and Conscientiousness. IIP-64C scores were significantly higher (>1 standard deviation) 
for all dimensions except Domineering (PA; > 0.9 standard deviation) compared to a
Norwegian normal reference sample [53], but at the same level as a Norwegian non-
psychotic outpatient sample [51]. Visual inspection of the normal curve displayed on 
histograms illustrating frequency distribution of scores, revealed normalization of 
scores through ipsation. Scores were highest for the IIP-64C Submissive/Friendly 
quadrant followed by the Submissive/Hostile quadrant and the Dominant/Friendly 
quadrant, with the lowest scores for the Dominant/Hostile quadrant (table 1). Scores in 
the Dominant/Hostile quadrant were significantly lower than the three other quadrants 
(versus Dominant/Friendly t = 2.76, p < 0.010; versus Submissive/Hostile t = 4.33, p 
0.001; and versus Submissive/Friendly t = 5.48, p < 0.001) and in the 
Submissive/Friendly quadrant significantly higher than the three other quadrants (versus 
Submissive/Hostile t = -2.05, p < 0.05; versus Dominant/Friendly t = -3.84, p < 0.001; 
and versus Dominant/Hostile t = -7.24, p < 0.001). There were no differences in NEO-
FFI or IIP-64C scores between men and women or between outpatients and inpatients. 
Higher patient WAI-S total scores were statistically significantly associated with lower 
levels of NEO-FFI Neuroticism and higher levels of Agreeableness, as well as lower 
levels of interpersonal problems in the IIP-64C Submissive/Hostile quadrant in bivariate 
analyses. There was a trend level association (p= .054) between NEO-FFI 
Agreeableness scores and therapist WAI-S total scores but no associations between any 
IIP-64C interpersonal problem scores and WAI-S therapist scores. For associations 
between personality variables and WAI-S sub scores, see table 2. 
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Table 2. Bivariate correlations (Spearman’s correlations (rho) between WAI-S patient/therapist total- and 
sub scores, NEO-FFI personality traits and IIP-64C interpersonal problems. 
WAI-S patient  
Spearman’s rho
WAI-S therapist
Spearman’s rho
Total Tasks Goals Bond Total Tasks Goals Bond
NEO-FFI (T-scores)
Neuroticism -.325* -.243 -.312* -.277 .024 .027 .202 -.115
Extraversion -197 .234 .043 .236 .103 .111 .009 .105
Openness .093 .201 .070 .017 -.109 -.153 -.219 .061
Agreeableness .317* .246 .230 .421** .300 .332* .146 .265
Conscientiousness .254 .146 .265 .177 -.089 -.085 -.121 -.008
IIP-64C (ipsated scores)
Dominant/Hostile (PA/BC) -.277 -.104 -.442** -.208 -.151 -.142 -.119 -.183
Submissive/Hostile (DE/FG) -.458** -.337* -.408** -.460** -.232 -.259 -.075 -.227
Submissive/Friendly (HI/JK) -.090 .040 -.094 -.1138 .068 .031 .171 -.023
Dominant/Friendly(LM/NO) -.100 -.023 -.299 -.037 .016 .023 .153 -.098
WAI-S = Working Alliance Inventory, short form; NEO-FFI = NEO Five-Factor Inventory; IIP-64C = Inventory of Interpersonal 
Problems 64 items Circumplex version. *=p<.05 **=p<.01. Significant correlations in bold.
[Table 2 in here]
Several NEO-FFI and IIP-64C scores were highly statistically significantly correlated 
and could thus not be fitted in the multiple linear regression analyses at the same time 
(table 3). 
Table 3. Bivariate correlations ( Pearson’s r) between NEO-FFI personality traits and IIP-64C 
interpersonal problems. 
NEO-FFI (T-scores)
Neuroticis
m
Extraversio
n
Opennes
s
Agreeablenes
s
Conscientiousnes
s
IIP-64C (ipsated scores)
Dominant/Hostile (PA/BC) .612** -.256 -.018 -.518** -.373**
Submissive/Hostile 
(DE/FG)
.729** -.499** -.150 -.510** -.424**
Submissive/Friendly 
(HI/JK)
.618** -.233 -.137 -.032 -.369*
Dominant/Friendly(LM/N
O)
.561** -.032 -.046 -.035 -.429**
NEO-FFI = NEO Five-Factor Inventory; IIP-64C = Inventory of Interpersonal Problems 64 items Circumplex version. *=p<.05 
**=p<.01. Significant correlations in bold.
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The hierarchical linear regression analyses indicated that a model including patients’
age, level of PANSS excitative symptoms and IIP-64C Submissive/Hostile had the best 
explanation of WAI-S patient total scores. The model accounted for 37% of the 
observed variance. Hierarchical linear regression analysis with therapist WAI-S total 
scores as the dependent variable indicated that PANSS insight (item G12) and NEO-FFI 
Agreeableness accounted for 23% of the observed variance (table 4). 
Table 4. Hierarchical linear regression analyses with WAI-S total scores as dependent variable:
Model summary Partial effects
R2 F ȕ t p 95% CI
Lower Upper
Patient WAI-S total 0.37 7.3
Age 0.27 2.03 0.049 0.002 1.076
+ PANSS excitative -0.25 -1.94 0.060 -2.585 0.054
+ IIP-64 Submissive/Hostile -0.39 -2.90 0.006 -5.143 -0.911
Therapist WAI-S total 0.23 5.7
Insight 
(PANSS item G12)
-0.36 -2.53 0.015 -3.781 -0.424
NEO-FFI Agreeableness 0.25 1.76 0.087 -0.028 0.402
WAI-S = Working Alliance Inventory, short form; NEO-FFI = NEO Five-Factor Inventory; IIP-64C = Inventory of Interpersonal 
Problems 64 items Circumplex version.
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4. Discussion
The main finding of this study was that both core traits of personality and interpersonal 
personality dimensions were clearly associated with patients’ experience of their 
working alliance with their therapist in bivariate analyses.  In multivariate analyses, the 
Submissive/Hostile quadrant of interpersonal problems, together with patient age and 
level of excitative symptoms accounted for more than one third of the observed variance 
in patient rated working alliance. 
High scores on the IIP-64C Submissive/Hostile quadrant reflects patients experiencing 
problems in feeling and expressing emotional and relational closeness, love and 
affection towards others, difficulties in establishing social relations and making long 
term commitments and in being sociable with others [48, 49]. To our knowledge, the 
importance of patients’ experience of interpersonal problems for the quality of the 
working alliance has not been previously shown in schizophrenia spectrum disorders. 
However, these results are consistent with findings from studies indicating that aspects 
of personality are associated with capacity for intimacy, levels of aggression and 
engagement with treatment services in schizophrenia [4, 54, 55], and suggest that 
personality factors may mediate these relationships. They are also in agreement with 
results from non-psychotic patient groups, indicating that submissive/hostile 
interpersonal problems are associated with patient reports of getting less out of their 
psychotherapy sessions compared to other patients [50]. In non-psychotic samples, 
poorer therapeutic alliance has also been found to be associated with interpersonal 
problems in the dominant/hostile domain [31, 56]. This suggests that it could be 
primarily the hostile elements of interpersonal problems that are associated with a 
poorer therapeutic alliance. 
Knowledge about submissive/hostile interpersonal problems should make therapists 
particularly attentive towards possible challenges to the working alliance. 
It is however important to note that this type of interpersonal problems were not 
characteristic of the current sample.  In fact, scores in the Submissive/Friendly quadrant 
were significantly higher than for other interpersonal problems. These patients thus 
mainly experienced interpersonal problems in being assertive towards others, clearly 
stating needs, feelings and communicating anger because of fear of how others might
respond [48]. The analyses however indicated that these interpersonal difficulties did 
not interfere with individual therapeutic relationships. From studies of non-psychotic 
samples it has been suggested that friendly/submissive qualities are in fact can be 
favorable to the process of therapy, such as greater openness to self-exploration and 
change, as well as more positive patient ratings of the working alliance [31, 56, 57].
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Higher levels of NEO-FFI Agreeableness were associated with therapists’ experience of 
the working alliance. The results thus indicate that patients describing themselves as 
being more empathic, helpful and trusting of others [58], in combination with higher 
levels of insight was important for the therapists experience. Therapist working alliance 
scores showed no association with patient experience of interpersonal problems. As 
NEO-FFI Agreeableness was clearly negatively associated with patient reports of 
interpersonal problems in both IIP-64C hostile quadrants there is fair reason to advice 
that therapists pay special attention to patients with core traits of personality 
characterized by low agreeableness. This is also in line with results from non-psychotic 
samples [59, 60].
We found a distinct interrelatedness between core personality traits and dimensions of 
interpersonal problems. Even after controlling for the general distress factor of the IIP-
64C through ipsation, all IIP-64C quadrants of interpersonal problems were positively 
associated with the personality trait of Neuroticism, which reflects difficult and 
disabling emotionality, and general psychological distress [58]. This contrasts with 
results from non-psychotic samples, where ipsation has been reported to remove the 
association between IIP-64C interpersonal problems and Neuroticism [49]. Taken 
together with the observation that the general levels of both NEO-FFI Neuroticism and 
IIP-64C interpersonal problems were high in this sample, this difference may reflect the 
heavy burden of both emotional and relational problems patients in the early treated 
phases of their disorder are facing. 
Generalizability of these results may be limited as the study sample size was moderate. 
Also subjects were assessed in a naturalistic treatment setting and not part of a 
standardized treatment program. The cross-sectional design prevents conclusions about 
causality.
Conclusion
Core traits of personality and dimensions of interpersonal problems are clearly 
associated with patients’ experience of their working alliance with their therapist. 
Interpersonal problems (Submissive/Hostile qualities), patient’s age and degree of 
excitative symptoms predict a considerable share of the variance in patient rated 
working alliance. Therapists perceive better working alliances with patients 
characterized by higher levels of Agreeableness and insight. Results highlight the 
relevance of addressing and exploring patients’ characteristic basic traits of personality 
and their subjectively experienced interpersonal problems.
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